WO2013192613A2 - Pvy resistance - Google Patents
Pvy resistance Download PDFInfo
- Publication number
- WO2013192613A2 WO2013192613A2 PCT/US2013/047329 US2013047329W WO2013192613A2 WO 2013192613 A2 WO2013192613 A2 WO 2013192613A2 US 2013047329 W US2013047329 W US 2013047329W WO 2013192613 A2 WO2013192613 A2 WO 2013192613A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant
- sequence
- polynucleotide
- sequences
- isolated polynucleotide
- Prior art date
Links
- 241000196324 Embryophyta Species 0.000 claims abstract description 222
- 241000723762 Potato virus Y Species 0.000 claims abstract description 113
- 238000000034 method Methods 0.000 claims abstract description 71
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 31
- 108091033319 polynucleotide Proteins 0.000 claims description 167
- 102000040430 polynucleotide Human genes 0.000 claims description 167
- 239000002157 polynucleotide Substances 0.000 claims description 166
- 244000061456 Solanum tuberosum Species 0.000 claims description 69
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 43
- 108020005120 Plant DNA Proteins 0.000 claims description 35
- 239000002773 nucleotide Substances 0.000 claims description 29
- 125000003729 nucleotide group Chemical group 0.000 claims description 29
- 230000009261 transgenic effect Effects 0.000 claims description 27
- 108020005202 Viral DNA Proteins 0.000 claims description 24
- 108090000623 proteins and genes Proteins 0.000 claims description 22
- 244000052769 pathogen Species 0.000 claims description 20
- 230000001717 pathogenic effect Effects 0.000 claims description 20
- 239000013604 expression vector Substances 0.000 claims description 19
- 208000015181 infectious disease Diseases 0.000 claims description 13
- 238000009396 hybridization Methods 0.000 claims description 12
- 241000894007 species Species 0.000 claims description 12
- 230000002068 genetic effect Effects 0.000 claims description 11
- 230000002441 reversible effect Effects 0.000 claims description 10
- 230000003612 virological effect Effects 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 8
- 238000009395 breeding Methods 0.000 claims description 6
- 102000039446 nucleic acids Human genes 0.000 claims description 6
- 108020004707 nucleic acids Proteins 0.000 claims description 6
- 150000007523 nucleic acids Chemical class 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 108020004999 messenger RNA Proteins 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 4
- 230000001488 breeding effect Effects 0.000 claims description 4
- 239000000872 buffer Substances 0.000 claims description 4
- 239000012634 fragment Substances 0.000 claims description 4
- 230000008929 regeneration Effects 0.000 claims description 4
- 238000011069 regeneration method Methods 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 3
- 238000003306 harvesting Methods 0.000 claims description 3
- 230000008635 plant growth Effects 0.000 claims description 3
- 230000001131 transforming effect Effects 0.000 claims description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims 2
- 230000000692 anti-sense effect Effects 0.000 claims 2
- 235000002634 Solanum Nutrition 0.000 abstract description 2
- 241000207763 Solanum Species 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 239000013598 vector Substances 0.000 description 22
- 241000706359 Solanum phureja Species 0.000 description 19
- 208000024891 symptom Diseases 0.000 description 19
- 241000700605 Viruses Species 0.000 description 18
- 108020004414 DNA Proteins 0.000 description 12
- 230000014509 gene expression Effects 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 238000011161 development Methods 0.000 description 9
- 230000018109 developmental process Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 244000027740 Solanum jamesii Species 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 238000003976 plant breeding Methods 0.000 description 7
- 230000009466 transformation Effects 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 5
- 241000589158 Agrobacterium Species 0.000 description 5
- 101100093450 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ubi::crp-6 gene Proteins 0.000 description 5
- 235000009869 Solanum phureja Nutrition 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 101710192640 Ribulose bisphosphate carboxylase/oxygenase activase Proteins 0.000 description 4
- 101710153769 Ribulose bisphosphate carboxylase/oxygenase activase, chloroplastic Proteins 0.000 description 4
- 241000607479 Yersinia pestis Species 0.000 description 4
- 230000030279 gene silencing Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 241001124076 Aphididae Species 0.000 description 3
- 101100184662 Caenorhabditis elegans mogs-1 gene Proteins 0.000 description 3
- 108700011259 MicroRNAs Proteins 0.000 description 3
- 241001327161 Solanum bulbocastanum Species 0.000 description 3
- 235000018967 Solanum bulbocastanum Nutrition 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 230000003111 delayed effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000012226 gene silencing method Methods 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 239000006870 ms-medium Substances 0.000 description 3
- 230000017074 necrotic cell death Effects 0.000 description 3
- 230000001338 necrotic effect Effects 0.000 description 3
- 229940027257 timentin Drugs 0.000 description 3
- GOSWTRUMMSCNCW-HNNGNKQASA-N 9-ribosyl-trans-zeatin Chemical compound C1=NC=2C(NC\C=C(CO)/C)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O GOSWTRUMMSCNCW-HNNGNKQASA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 206010061818 Disease progression Diseases 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241000227653 Lycopersicon Species 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 2
- 241001264008 Solanum microdontum Species 0.000 description 2
- 235000017598 Solanum microdontum Nutrition 0.000 description 2
- 108700019146 Transgenes Proteins 0.000 description 2
- 102000023732 binding proteins Human genes 0.000 description 2
- 108091008324 binding proteins Proteins 0.000 description 2
- 229930002868 chlorophyll a Natural products 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 229930002869 chlorophyll b Natural products 0.000 description 2
- NSMUHPMZFPKNMZ-VBYMZDBQSA-M chlorophyll b Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C=O)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 NSMUHPMZFPKNMZ-VBYMZDBQSA-M 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000005750 disease progression Effects 0.000 description 2
- 230000009368 gene silencing by RNA Effects 0.000 description 2
- JLJLRLWOEMWYQK-GDUNQVSHSA-N giberellic acid Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)C1C(O)=O)CC2[C@@]2(OC3=O)C1[C@]3(C)[C@@H](O)CC2 JLJLRLWOEMWYQK-GDUNQVSHSA-N 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 239000012212 insulator Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002679 microRNA Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 235000012015 potatoes Nutrition 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- GOSWTRUMMSCNCW-UHFFFAOYSA-N trans-zeatin riboside Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1OC(CO)C(O)C1O GOSWTRUMMSCNCW-UHFFFAOYSA-N 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102100025570 Cancer/testis antigen 1 Human genes 0.000 description 1
- 108090000565 Capsid Proteins Proteins 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- YAHZABJORDUQGO-NQXXGFSBSA-N D-ribulose 1,5-bisphosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)C(=O)COP(O)(O)=O YAHZABJORDUQGO-NQXXGFSBSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 description 1
- 101000804764 Homo sapiens Lymphotactin Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 102100035304 Lymphotactin Human genes 0.000 description 1
- 102000013460 Malate Dehydrogenase Human genes 0.000 description 1
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 102100026459 POU domain, class 3, transcription factor 2 Human genes 0.000 description 1
- 101710133394 POU domain, class 3, transcription factor 2 Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 241001533393 Potyviridae Species 0.000 description 1
- 241000710078 Potyvirus Species 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000012881 co-culture medium Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 229930002203 giberellic acid Natural products 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000009399 inbreeding Methods 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000005727 virus proliferation Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
Definitions
- the present inventive technology relates to the expression of recombined genetic elements from potato plants, e.g., Solatium phureja, and/or recombined genetic elements from Potato Virus Y (PVY) to confer broad-spectrum Potato Virus Y (PVY) resistance to intragenic plants.
- Potato Virus Y PVY
- PVY Potato Virus Y
- PVY Potato virus Y
- Potyviridae a member of the family Potyviridae
- NMVY Potato virus Y
- Some PVY resistant and tolerant varieties have been developed through traditional plant breeding, but none of these varieties were widely adopted because they lack important traits required by the industry. Efforts to introgress PVY resistance into the most popular cultivars are complicated by complex autotetrapioid genetics, numerous prezygotic and postzygotsc barriers, and inbreeding depression.
- One aspect of the present invention is an isolated polynucleotide comprising multiple plant DNA sequences, wherein each plant DMA sequence shares sequence homology to a corresponding DNA sequence from the genome(s) of at least one strain of Potato Virus Y.
- the isolated polynucleotide comprises 2, 3, 4, 5, 6, 7, 8, 9, 10, or more than 10 plant D!MA sequences.
- each plant DNA sequence of the polynucleotide shares at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence homology with a PVY DNA sequence, in one embodiment, the plant DNA sequences are potato plant DNA sequences.
- each plant DNA sequence of the polynucleotide shares at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence homology to potato, and is selected from the group consisting of Ranger Russet, Russet Burbank, Atlantic, Phureja and Shepody.
- the plant DNA sequences within the polynucleotide are sequences from the genome of the same potato variety.
- the plant DNA sequences within the polynucleotide are sequences from multiple genomes of different potato varieties
- the polynucleotide comprises potato plant DNA sequences selected from one or more of sequences endogenous to Ranger Russet, Russet Burbank, Atlantic, and Shepody potato varieties.
- the DNA source is a wild potato species such as Solanum phureja, Solanum microdontum, Solanum bulbocastanum
- the polynucleotide in the vector comprises one or more sequences selected from the group consisting of SEQ ID NOs.
- each viral DNA sequence is derived from the same and/or different strain of Potato Virus Y, wherein each virai DNA sequence shares high sequence homology to a DNA sequence from the genome(s) of a plant, for example, a potato plant.
- each viral DMA sequence of the polynucleotide shares at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence homology with a plant DNA sequence.
- the isolated polynucleotide comprises 2, 3, 4, 5, 6, 7, 8, 9, 10, or more than 10 viral DNA sequences.
- the viral DNA sequences share high homology to the DNA sequences from the genome of the same potato variety.
- the virai DNA sequences share high homology to sequences from multiple genomes of different potato varieties.
- the potato is selected from the group consisting of Ranger Russet, Russet Burbank, Atlantic, Phureja and Shepody.
- the potato plant is a wild potato species such as Solanum phureja, Solarium microdontum, or Solanum bulbocastanum.
- Another aspect of the present invention is an expression vector comprising a promoter operably linked to a polynucleotide comprising multiple plant DNA sequences, wherein each plant DNA sequence shares sequence homology to a corresponding DNA sequence from the genome(s) of at least one strain of Potato Virus Y.
- the polynucleotide in the vector comprises one or more sequences selected from the group consisting of SEQ ID NOs.
- Another aspect of the present invention is an expression vector comprising a promoter operabiy linked to a polynucleotide comprising multiple viral DNA sequences, wherein viral DNA sequence shares high sequence homology to a DNA sequence from the genome(s) of one or more plant species/varieties., such as one or more potato species/varieties.
- the polynucleotide in the vector comprises one or more sequences selected from the group consisting of SEQ ID NOs. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 45, 48, 53, and 57.
- Another aspect of the present invention is a method for conferring full or partial resistance in a plant to at least one strain of Potato Virus Y infection, comprising expressing in a plant a polynucleotide that comprises multiple plant DNA sequences, wherein each plant DNA sequence shares sequence homolog to a corresponding DNA sequence from the genome(s) of at least one strain of Potato Virus Y, wherein the plant is fully or partially resistant to PVY infection compared to a plant of the same species that does not express the polynucleotide, in one embodiment, the plant is a potato plant.
- the potato is selected from the group consisting of Ranger Russet, Russet Burbank, Atlantic, Phureja and Shepody.
- the plant DNA sequences within the polynucleotide are sequences from the genome of the same potato variety. In another embodiment, the plant DNA sequences within the polynucleotide are sequences from multiple genomes of different potato varieties. In another embodiment the sequences are from a wild potato species such as Soianum phureja, Soianum microdontum, Solarium buibocastanum. In one embodiment, the polynucleotide comprises potato plant DNA sequences selected from one or more of sequences endogenous to Ranger Russet, Russet Burbank, Atlantic, Shepody potato varieties, or a wild potato species.
- the plant DNA sequences are potato plant DNA sequences
- the plant in another embodiment of this method.
- the plant is a potato plant and the plant DNA sequences are potato plant DNA sequences.
- the polynucleotide in the vector comprises one or more sequences selected from the group consisting of SEQ ID !MQs, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, and 103.
- Another aspect of the present invention is a method for conferring full or partial resistance in a plant to at least one strain of Potato Virus Y infection, comprising expressing in a plant a polynucleotide that comprises multiple viral DNA sequences, wherein each viral DNA sequence shares sequence homology to a DNA sequence from the genome(s) of a plant, wherein the plant is fully or partially resistant to PVY infection compared to a plant of the same species that does not express the polynucleotide.
- the plant is a potato plant.
- the potato is selected from the group consisting of Ranger Russet, Russet Burbank, Atlantic, Phureja and Shepody.
- the viral DNA sequences within the polynucleotide are sequences sharing homology to the genome of the same potato species/variety. In another embodiment, the viral DNA sequences within the polynucleotide are sequences sharing homology to multiple genomes of different potato species/varieties.
- the sequences share homology to the genome of a wild potato species such as So!anum phureja, Solanum microdontum, Solanum bulbocastanum
- the polynucleotide shares homology to a sequence comprises potato plant DNA sequences selected from one or more of sequences endogenous to Ranger Russet, Russet Burbank, Atlantic, Shepody potato varieties, or a wild potato species, in one embodiment of this method, the plant DNA sequences are potato plant DNA sequences.
- the polynucleotide comprises one or more sequences selected from the group consisting of SEQ ID NOs. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 45, 48, 53, and 57.
- a polynucleotide of the present invention comprises at least two sequences selected from the SEQ ID NOs.: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12. In another embodiment, the polynucleotide comprises the sequence of SEQ ID NO: 13.
- a polynucleotide of the present invention comprises at least two sequences selected from the SEQ ID NOs.: 60.. 61, 62.. 63, 64, 65, 66, 67, 68, 69, 70, and 71.
- a polynucleotide of the present invention comprises at least two sequences selected from the SEQ ID NOs.: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, and 25. In another embodiment, the polynucleotide comprises the sequence of SEQ ID NO: 26.
- a polynucleotide of the present invention comprises at least two sequences selected from the SEQ ID NOs.: 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82.. and 83, or at least two sequences selected from the SEQ ID NOs.: 84, 85.86,87, 88, 89, 90, 91, 92, 93, 94, and 95, or at least two sequences selected from the SEQ ID NOs.: 96, 97, 98, 99, 100, 101, 102, and 103.
- a polynucleotide of the present invention comprises at least two sequences selected from the SEQ I D NOs. : 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, and 38.
- the polynucleotide comprises the sequence of SEQ I D NO: 39.
- a polynucleotide of the present invention comprises at least two sequences selected from the SEQ I D NQs,: 45, 48, 53, and 57.
- the polynucleotide comprises the sequence of SEQ I D NO: 58.
- a polynucleotide of the present invention comprises one or more sequences selected from the group consisting of: (1) complements of a sequence of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 45, 48, 53, and 57; (2) reverse complements of a sequence of 1, 2, 3, 4, 5, 6, 7.
- stringent conditions are hybridization in 0.25 M a2H P04 buffer (pH 7.2 ⁇ containing 1 mM IMa2EDTA, 20% sodium dodecyi sulfate at 45°C, followed by a wash in SxSSC, containing 0.1% (w/v) sodium dodecyi sulfate, at 55°C to 65°C.
- a polynucleotide of the present invention comprises one or more sequences selected from the group consisting of: (1) complements of a sequence of SEQ ID NOs: 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, and 103; (2) reverse complements of a sequence of 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87,
- a polynucleotide of the present invention comprises (1) one or more plant DNA sequence, wherein each plant DNA sequence shares sequence homology to a
- each viral DNA sequence shares sequence homology to a corresponding DNA sequence from the genome(s) of at least one plant, such as a potato plant.
- each plant DNA sequence shares at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more sequence homology with a PVY DNA sequence.
- the polynucleotide comprises at least one sequence selected from SEQ ID NOs.: 60-83, or reverse complements thereof.
- each viral DNA sequence shares at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more sequence homology with a potato plant DNA sequence.
- the polynucleotide comprises at least one sequence selected from SEQ ID Qs. 1-38, 45, 48, 53, 57, and 58, or reverse complements thereof.
- an expression vector of the present invention comprises a polynucleotide described herein.
- the present invention also provides transgenic cells comprising a polynucleotide described herein, or organisms comprising said transgenic cells.
- transgenic plants, plant parts, or plant ceils are also provided.
- seeds of the transgenic plants are provided, wherein said seed comprises said isolated polynucleotide.
- progeny plants of the transgenic plants are provided, wherein the progeny plants have an altered pathogen tolerance and/or resistance as a result of inheriting the polynucleotide.
- the present invention also provides methods for producing hybrid seeds, in one
- the methods comprise crossing at least one transgenic plant or a progeny plant of the present invention with a second plant.
- the second plant is a different plant of the same species, or a related species, in one embodiment, the second plant is a different plant of the same variety, or a different variety, in one embodiment, the methods comprise harvesting the resultant seed.
- the present invention also provides methods for producing a plant having altered pathogen tolerance and/or resistance.
- the methods comprise transforming a plant cell with an expression vector to provide a transgenic ceil.
- the expression vector comprises: (i) a promoter sequence; (ii) an isolated polynucleotide sequence of the present invention; and (iii) a gene termination sequence, in one embodiment, the methods further comprise cultivating the transgenic cell under conditions conducive to regeneration and mature plant growth of a plant having altered pathogen tolerance and/or resistance.
- the present invention also provides methods for modifying a phenotype of a target organism, in one embodiment, the methods comprise stably incorporating into the genome of the target organism a genetic construct.
- the genetic construct comprises: (a) a promoter sequence; (b) an isolated polynucleotide sequence of the present invention; and (c) a gene termination sequence.
- the target organism is a plant.
- the present invention also provides processes of determining the presence or absence of an isolated polynucleotide sequence of the present invention, or fragments and variations thereof in a plant, in one embodiment, the processes are based on DMA hybridization, RNA hybridization, and/or protein hybridization. In one embodiment, the processes comprise at least one of: (a) isolating nucleic acid molecules from said plant and amplifying sequences homologous to the polynucleotide; (b) isolating nucleic acid molecules from said plant and performing a hybridization to detect the polynucleotide; and (c) demonstrating the presence of mRNA sequences derived from a polynucleotide mRNA transcript and unique to the polynucleotide.
- the present invention also provides methods for breeding plants to produce altered pathogen tolerance and/or resistance.
- the methods comprise making a cross between a first plant with an isolated polynucleotide sequence of the present invention with a second plant to produce a Fl plant, in one embodiment, the methods further comprise backcrossing the Fl plant to the second plant.
- the methods further comprise repeating the backcrossing step to generate a near isogenic or isogenic line, wherein the isolated polynucleotide sequence of the present invention is integrated into the genome of the second plant and the near isogenic or isogenic line derived from the second plant with the isolated polynucleotide sequence has conferred or enhanced pathogen tolerance and/or resistance compared to that of the second plant without the isolated polynucleotide sequence.
- PVY Potato virus Y
- a new approach for conferring resistance to Potato virus Y (PVY) in plants is described herein and is based upon the expression of nucleotide sequences that are endogenous to the genomes of both PVY and species of Solanum.
- Genetically engineered plants that are resistant to PVY and which express polynucleotides obtained from within the plant's own gene pool, as is the case for conventional plant breeding are highly desirable (Rommens CM, Haring MA, Swords K, Davies HV, Belknap WR (2007) The intragenic approach as a new extension to traditional plant breeding. Trends Plant Sci 12: 397-403, which is incorporated herein by reference in its entirety).
- multiple discontiguous regions of intergenic and/or intragenic DNA from the wild potato species Solanum phureja are recombined, operably linked to a promoter and terminator, and transformed into a cultivated plant susceptible to potato virus Y (PVY).
- the promoter is selected from the group consisting of constitutive promoters, non-constitutive promoters, inducible promoters, tissue-specific promoters, and developmental stage-specific promoters.
- the tissue-specific promoter is a leaf- specific promoter or a shoot-specific promoter, such as the promoters associated with ribulose 1,5- bisphosphate carboxylase (RUBISCO), chlorophyll A/B binding protein (CAB), rubisco activase (RA), early light inducible protein (EL!P), glyoxysomal maiate dehydrogenase (gMDH), and those described in U.S. Pat, No. 7534934 and U.S. Pat, Appl. Pub!. Nos. 20080301837 and 20090220670, each of which is incorporated by reference in its entirety.
- the tissue-specific promoter does not drive gene expression in the tuber.
- viral sequences which share high homology to plant genome sequences. Due to the high homology to plant genome sequences, such viral sequences are more likely to be deemed safe and therefore be perceived as being more acceptable to the public. Therefore, multiple discontiguous regions of DNA from a virus that share high homology to the DNA of potato plants, such as the wild potato species Solanum phureja can be recombined, operabiy linked to a promoter and terminator, and transformed into a cultivated plant susceptible to potato virus Y (PVY).
- PVY potato virus Y
- the promoter is selected from the group consisting of constitutive promoters, non-constitutive promoters, inducible promoters, tissue-specific promoters, and developmental stage-specific promoters.
- the tissue-specific promoter is a leaf-specific promoter or a shoot-specific promoter, such as the promoters associated with ribuiose 1,5-bisphosphate carboxylase (RUBISCO), chlorophyll A/B binding protein (CAB), rubisco activase (RA), early light inducible protein (BLIP), giyoxysomal malate dehydrogenase (gMDH), and those described in U.S. Pat. No. 7534934 and U.S. Pat. Appl. Publ. Nos. 20080301837 and 20090220670, each of which is incorporated by reference in its entirety.
- the tissue-specific promoter does not drive gene expression in the tuber.
- the cassette into plants results in the production of RNA transcripts that target the PVY genome for degradation through various mechanisms, such as RNA interference.
- RNA interference RNA interference.
- the development of PVY resistance through expression of several discontiguous endogenous DNA elements as single DNA element to target multiple and specific regions of a viral polyribonucleotide while reducing the public's concern of permanent introduction of foreign DNA in to plants is a novel and inventive approach to conferring PVY resistance to a plant.
- the present invention encompasses methods for identifying in a plant genome endogenous one or more nucleotide sequences that share sequence identity with a corresponding sequence or sequences endogenous to the PVY genome.
- the present invention encompasses methods for identifying one or more viral genome nucleotide sequences that share high (e.g., >90%) or very high (e.g., >95%) homology with a sequence or sequences endogenous to the plant genome.
- One way this can be done is by aligning pu blicly available PVY sequences against plant DNA databases, such as GenBank. The alignment can then be analyzed for regions of conservation among the aligned sequences.
- the genome sequence information of potato species, such as S. tuberosum and 5. phureja is publicly available and can be obtained through the Potato Genome Sequencing Consortium database. The tomato genome sequence is recently released by the Tomato Genome Consortium (Nature, 2012, 485:635-641).
- the endogenous nucleotide sequences in the plant genome are intergenic sequences, in one embodiment, the intergenic sequences do not encode any functional polypeptides.
- the endogenous nucleotide sequences in the plant genome are intragenic sequences (e.g., cis-elements, exons, introns, 5' or 3' terminal sequences).
- the endogenous nucleotide sequences in the plant genome encode functional polypeptides which when suppressed do not bring any undesired plant phenotypes.
- Regions of high genetic conservation among PVY strains can also be searched for PVY sub- regions of high homology, e.g., greater than, for instance, at least 90% homology., to the sequenced and publicly available plant genome, such as to the Solanum Phureja genome provided by the Potato Genome Sequence Consortium.
- alignment programs such as those provided by the NCBI BLAST analysis, is useful in this regard.
- These highly identical PVY su b-regions can then be analyzed for homology with potato cDNAs, and desired sequences sharing homology to any cDNA can be identified and prioritized.
- These prioritized sequences therefore are sequences that are highly identical to sequences represented by the genomes of the various PVY strains, and also highly (e.g., >90%) or very highly (e.g., >95%) identical to sequences represented by the genomes of the various plant
- one or more of these sequences can be used in an expression vector.
- two or more expression vectors each comprising at least one of the prioritized sequences can be introduced into a plant.
- a binary vector system is used, such as those described in U.S. Pat. No, 7923600, which is incorporated by reference in its entirety.
- two or more of these sequences can be joined together to yield a single polynucleotide within which two or more plant-derived, PVY-homo!ogous sub-sequences, or two or more virus-derived, plant homologous sub-sequences, or at least one plant-derived, PVY-homologous sub-sequence and at least one virus-derived, plant homologous subsequence.
- polynucleotide there may be sequences derived from plants that are identical to, or highly or very highly homologous to, sequences present in one or more strains of PVY.
- polynucleotide there may be sequences derived from virus that are identical to, or highly or very highly homologous to, sequences present in one or more plant species/varieties.
- polynucleotide there may be sequences derived from plants that are identical to, or highly or very highly homologous to, sequences present in one or more strains of PVY, and sequences derived from virus that are identical to, or highly or very highly- homologous to, sequences present in one or more plant species/varieties.
- the two or more sequences can be joined together in any order, in any way, by any method as suitable.
- one or more copies of each sequence are joined, in one embodiment, each sequence is directly joined.
- an "insulator" sequence is included between the joined sequences, in one embodiment, the "insulator” sequence does not share any homology or very little homology to any sequence of the plant and/or PVY.
- the single polynucleotide produces at least one interference RNA against PVY when transcribed.
- the single polynucleotide comprises one or more inverted repeats, antisertses, and/or hairpin structures.
- Resistance a resistant plant is able to limit PVY proliferation and/or PVY-caused disease symptom development when compared to a plant that is not resistant.
- resistance is a relative concept.
- the transgenic resistant plants described in this invention are able to limit PVY proliferation and/or PVY-caused disease symptom development compared to their untransformed counterparts. For example, the plants show no symptoms or show some symptoms but that are still able to produce marketable product with an acceptable yield.
- ISF Internationa! Seed Federation
- the recognition of whether a plant is affected by or subject to a pest or pathogen can depend on the analytical method employed. Resistant plant types may still exhibit some disease symptoms or damage.
- the resistance can be either high (e.g., the growth and development of the specified pest or pathogen is highly restricted under normal pest or pathogen pressure when compared to susceptible varieties), or moderate/intermediate (e.g., the growth and development of the specified pest or pathogen is restricted, but the plants exhibit a greater range of symptoms or damage compared to plant types with high resistance).
- a plant is resistant to the virus strain if it has a virus RNA and/or protein density that is about 50%, about 40%, about 30%, about 20%, about 10%, about 5%, about 2%, about 1%, about 0.1%, about 0.01%, about 0.001%, or about 0.0001% of the RNA and/or protein density in a control plant.
- full resistance in the context of the present invention means that, after being infected with the PVY virus, no viral proliferation is detected and/or no PVY-caused symptoms are observed the entire length of an experiment., which is usually 2-4 weeks.
- partial resistance in the context of the present invention means that, the plants have reduced multiplication of the virus in the cell, as reduced (systemic) movement of the virus, and/or as reduced symptom development after infection compared to susceptible plants.
- the resistance is often referred to as “intermediate resistance”.
- delayed disease progression or “delayed disease symptoms” or “to resist the onset of one or more symptoms of PVY disease” or “partial resistance” in the context of the present invention means that PVY proliferation and/or PVY-caused disease symptom development is limited in a plant compared to another plant, whereby limited should be interpreted here to mean that PVY proliferation and/or PVY-caused disease symptom development is not fully prevented.
- the transformed plant may display disease symptoms 1-3 days, 3-5 days, 5-7 days, 7-9 days, 9-11 days, 11-13 days, 13-15 days, 2-3 weeks, 3-4 weeks, 4-5 weeks, 5-7 weeks, 7-10 weeks, 2-3 months and 3-5 months later than the untransformed plant.
- Transformed plants with delayed disease progression typically carry the PVY virus protein upon infection.
- the PVY virus protein can be detected via ELISA assay. The length of the symptom delay varies.
- orthologs and paralogs of the sequences disclosed herein are also part of the invention.
- the term "ortholog” refers to genes in different species that evolved from a common ancestral gene by speciation. Normally, orthologs retain the same function in the course of evolution. Identification of orthologs is critical for reliable prediction of gene function in newly sequenced genomes.
- the term "paralog” refers to genes related by duplication within a genome. While orthologs generally retain the same function in the course of evolution, paralogs can evolve new functions, even if these are related to the original one.
- PVY Potato virus Y
- PVY Potato virus Y
- aphids the type member of the largest group of plant viruses. It is transmitted by aphids in a nonpersistent manner, by sticking to aphid mouthparts (stylet). The virus can be acquired from the infected plant within seconds, and transmitted to a healthy plant just as fast. PVY can also be transmitted mechanically by machinery, tools., and damaging plants while walking through the field. Aphids are by far the most efficient means of transmission.
- PVY 0 is the common strain, and causes mosaic symptoms. PVY 1' causes stipple streak.
- PVY N the necrotic strain, generally causes mild foliage symptoms, but necrosis in the leaves of susceptible potato varieties. Mixed infections of common strains and the necrotic strain are common, and the genomes (genetic material) can mix, producing hybrid strains (i.e. PVY N:i!> and PVY rJ N ). PVY rJ N strains can cause tuber necrosis, and are of increasing importance in New York.
- PVY sequences are provided in GenBank accession numbers: X97895, X12456, M95491 D00441, U09509, NC_001616, JN034046, JF928460, JF928459, JF928458, JF795485, HQ912915, HQ912914, HQ912913, HQ912912, HQ912911, HQ912910, HQ912909, HQ912908, HQ912907, HQ912906, HQ912905, HQ912904, HQ912903, HQ912902, HQ912901, HQ912900, HQ912899, HQ912898, HQ912897, HQ912896, HQ912895, HQ91
- HM590405 HM 367076, HM367075, GQ200836, FJ666337, FJ643479, FJ643478, FJ643477, FJ214726, FJ204166, FJ204165, FJ204164, EU563512, EU482153, EU182576, EF558545, EF026076, EF026075, EF026074, EF016294, DQ309028, DQ157180,
- the polynucleotides of the present invention can be introduced into a plant by any suitable method, such as Acjro bacterium-mediated transformation, viral infection, whiskers, eiectroporation, microinjection, polyethylene g!ycol-treatmertt, heat shock, iipofection and particle bombardment.
- Transformation of a plant is a process by which DMA is stably integrated into the genome of a plant ceil.
- Stably refers to the permanent, or non-transient retention and/or expression of a polynucleotide in and by a cell genome.
- a stably integrated polynucleotide is one that is a fixture within a transformed cell genome and can be replicated and propagated through successive progeny of the cell or resultant transformed plant. Transformation may occur under natural or artificial conditions using various methods well known in the art. See, for instance, METHODS IN PLANT MOLECULAR BIOLOGY AND BIOTECHNOLOGY, Bernard R. Giick and John E. Thompson (eds), CRC Press, inc., London (1993); Chilton, Scientific American, 248) (6), pp. 36-45, 1983; Bevan, Nucl. Acids. Res., 12, pp.
- Plants also may be transformed using "Refined Transformation” and "Precise Breeding” techniques. See, for instance, Rommens et al. in New Zealand Patent 535,395, U.S. Pat. No. 7,250,554, U.S. Pat. No. 7,534,934, WO2005/004585, U.S. Pat. No. 7,598,430, US-2005- 0034188, US-2012-01Q25S9, WO2QQ5/Q02994, and New Zealand Patent 536,037, which are ail incorporated herein by reference.
- Any method suitable for gene silencing in plants can be used.
- Non-limiting examples of gene silencing methods in plants are described in U.S. Patent Nos. 8058509, 7320892, 7754697, 7417180, 7816581, 7902425, 8395023, 7807880, 8362323, 8293977, and 7928289; U.S. Patent Application Publication Nos.
- a silencing vector comprises two or more promoters which flank one or more desired polynucleotides or which flank copies of a desired polynucleotide, such that both strands of the desired polynucleotide are transcribed. That is, one promoter may be oriented to initiate transcription of the 5'-end of a desired polynucleotide, while a second promoter may be operably oriented to initiate transcription from the 3'-end of the same desired polynucleotide.
- the oppositely-oriented promoters may flank multiple copies of the desired polynucleotide, as described in U.S. Patent Nos. 7713735 and 8158414, each of which is herein incorporated by reference in its entirety for all purposes.
- the identification is based on detecting the presence or absence of any fragment of the transgene described herein, such as the promoter sequence, the termination sequence, the selection marker, or the polynucleotide sequence having similarity to the PVY sequence.
- methods based on DNA hybridization e.g., PGR, Southern blot
- the identification is based on detecting the presence or absence of any RNA transcript encoded by the transgene described herein.
- methods based on RNA hybridization e.g., RT-PCR, Northern blot
- the identification is based on detecting the presence or absence of resistance to PVY. In one embodiment, two or more methods described above are combined.
- classic breeding methods can be included in the present invention to introduce one or more recombinant genes of the present invention into other plant varieties, or other close-related species that are compatible to be crossed with the transgenic plants of the present invention.
- Such techniques include, but are not limited to, Open-Pollinated Populations, Mass Selection, Synthetics, Pedigreed varieties, and Hybrids.
- a potato derived sequence for broad-spectrum PVY control was defined as follows:
- PVY Potato Virus Y
- the alignment was analyzed for candidate conserved regions.
- the identified regions were validated and ranked for broad-spectrum sequence conservation against a pool of 800+ partial PVY sequence accessions.
- the prioritized genetic elements which were highly conserved to both the PVY genetic spectrum and potato intergenic sequence were then joined, yielding a "425bp molecule comprised of 12 genetic elements.
- the junctions of flanking potato DMA elements were engineered to share a short region of overlapping homology to PVY sequence. For example, the first 5bp of the potato DMA comprising SEQ ID NO: 3 shares perfect homology to the 5bp of PVY sequence beyond the target region of SEQ ID NO:2.
- one or more plant derived sequences that share high or very high homology to the virus-derived sub-regions can be joined. Such joined sequences can be used to introduce PVY resistance into plants as well.
- polynucleotide SEQ ID NO: 13 comprising SEQ ID NO: 1-12, is operabiy linked to promoter Ubi7 SEQ ID NO: 58 and terminator Ubi3 SEQ ID NO: 59, The resulting expression cassette is positioned within a T-DNA region of a binary vector to produce pSIM2201.
- transformation vector will be introduced into an Agrobacterium strain such as LBA4404 or AGL-1 as follows.
- Competent LB4404 ceils (50 ⁇ !_) are incubated for 5 min on ice in the presence of l,ug of vector DNA, frozen for about 15 s in liquid nitrogen, and incubated at 37°C for 5 min. After adding 1 ml. of liquid broth, the treated cells are grown for 3 h at 28°C and plated on liquid broth/agar containing streptomycin (100 mg/L) and kanamycin (100 mg/L). The vector DNAs are then isolated from overnight cultures of individual LBA4404 colonies and examined by restriction analysis to confirm the presence of intact piasmid DNA.
- Ten-fold dilutions of overnight-grown Agrobacterium cultures can be grown for 5-6 hours, precipitated for 15 minutes at 2,800 RPM, washed with MS liquid medium (Phytotechno!ogy) supplemented with sucrose (3%, pH 5.7), and resuspended in the same medium to 0.2 OD/600nm.
- the resuspended cells are mixed and used to infect 0.4-0.6 mm internodal segments of the potato varieties Ranger Russet, Russet Burbank, Atlantic, Phureja and Shepody.
- Infected stems are incubated for two days on co-culture medium (1/10 MS salts.. 3% sucrose.. pH 5.7) containing 6 g/L agar at 22°C in a Percival growth chamber (16 hrs light) and subsequently transferred to callus induction medium (CIM, MS medium supplemented with 3% sucrose 3, 2.5 mg/L of zeatin riboside. 0.1 mg/L of naphthalene acetic acid, and 6g/L of agar) containing timentin (150 mg/L) and kanamycin (100 mg/L).
- co-culture medium (1/10 MS salts.. 3% sucrose.. pH 5.7
- CCM callus induction medium
- MS medium MS medium supplemented with 3% sucrose 3, 2.5 mg/L of zeatin riboside.
- timentin 150 mg/L
- kanamycin 100 mg/L
- expiants are transferred to shoot induction medium (SIM, MS medium supplemented with 3% sucrose, 2.5 mg/L of zeatin riboside, 0.3 mg/L of giberellic acid GA3, and 6g/L of agar) containing timentin and kanamycin (150 and 100 mg/L respectively) until shoots arise.
- Shoots arising at the end of regeneration period are transferred to MS medium with 3% sucrose, 6 g/L of agar and timentin (150mg/L).
- Transgenic plants are transferred to soil and placed in a growth chamber. The transformed plants are challenged by PVY as follows.
- an inoculum of PVY strain "NTN" or "0" is prepared fresh for each infection by grinding 5 g of systemicai!y infected tobacco tissue in 15 ml ice-cold phosphate buffer. The resulting suspension is filtered through miraclofh, and kept on ice. One drop of inoculum is gently rubbed on a single carborundum-dusted leaf from each plant transferred from tissue culture to soil six weeks earlier. Plants are grown for an additional 2-3 weeks to facilitate systemic viral spread and symptom development. All experiments are carried out in triplicate. Plants are assessed for the presence of PVY using the "ImmunoStrip" affinity assay that relies on previously characterized antibodies (Ellis et aL, 1996) and was developed by Agdia (Elkhart, IN).
- polynucleotide SEQ ID NO: 26 consisting of SEQ ID NO: 14-25, is operabiy linked to promoter Ubi7 SEQ ID NO: 58 and terminator Ubi3 SEQ ID MO: 59 to produce pSI 2202.
- polynucleotide SEQ ID MO: 39 consisting of SEQ ID NO: 27-38, is operabiy linked to promoter Ubi7 SEQ ID NO: 58 and terminator Ubi3 SEQ iD NO: 59 to produce pSI 2203.
- polynucleotide SEQ ID NO: 57 consisting of SEQ ID NO: 45, 48, 53, & 56 to produce pSI 2204, is operabiy linked to promoter Ubi7 SEQ ID NO: 58 and terminator Ubi3 SEQ ID NO: 59.
- Element 57 is not constructed the same way as 13, 26 and 39. In this case if is an miRNA approach and it contains much more potato sequences than PVY sequences.
- Example 3 pSIM2201, pSI 2202, pSI 2203, and pS!M2204 were made according to the method described in Example 2, and transformed into Russet Burbank variety to produce transgenic potato plants RB-
- RB-2201 plants contain a construct pSIM2201 with
- SEQ ID 13 (combination of SEQ ID NOs: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 & 12).
- RB-2202 plants contain a construct pSIM2202 with SEQ ID 26 (combination of SEQ ID NOs: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- RB-2203 plants contain a construct pSIM2203 with SEQ ID 39 (combination of SEQ ID NOs: 27, 28,
- PVY virus was rub-inoculated to the transgenic plants.
- PVY immuno detection was performed by using lmmunoStrip ® !SK 20001/0025 from Agdia.. 20 days post rub inoculation on Russet Burbank transgenic lines. The initial test result is shown in the table below'. !br of plants PVY ImmunoStrip
- Russet Burbank 3 Positive Control plant is susceptible to PVY N i
- RB-2201 plants contain a construct with SEQ I D 13 (1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 & 12)
- RB-2202 plants contain a construct with SEQ ID 26 (14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 & 25)
- RB-2203 plants contain a construct with SEQ I D 39 (27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 & 38)
- RB-2204 plants contain a construct with SEQ ID 57 (45, 48, 53 & 56)
- transgenic plants RB-2203 and RB-2204 did not show obvious resistance to PVY in the initial trial, it does not mean that the silencing sequences targeting PYV in these vectors, i.e., SEQ ID NOs: 39 and 57, do not have the ability to induce PVY resistance in plants. It does not mean that every single sub-sequence within SEQ I D NQs: 39 or 57 could not be combined with other sequences to make additional vectors capable of inducing PVY resistance in plants. Many reasons may cause a false negative result. For example, there may be a particular mistake in pS!M2203 and pS!
- the vectors may have been suppressed in the plant genome; the vectors may not be particularly suitable for expressing SEQ ID NOs: 39 or 57 in plants since such sequences are much longer compared to other sequences; there may be a particular sub-sequence in the vectors that caused suppression of the expression of the whole vectors, etc. in addition, this is just one-time experiment so the negative data should not lead to a final conclusion that the vectors do not work.
- a polynucleotide comprising at least two potato sequences selected from SEQ ID MO: 60-103, is operab!y linked to promoter Ubi7 SEQ ID NO: 58 and terminator Uhi3 SEQ ID NO: 59.
- the resulting expression cassette is positioned within a T-DNA region of a binary vector.
- This transformation vector will be introduced into an Agrobacterium strain such as LBA4404 or AGL-1 as described in Example 2 above.
- a polynucleotide comprising at least one viral sequence selected from SEQ ID MOs: 1-58, and at least one potato sequence selected from SEQ ID NOs: 60-103, is operabiy linked to promoter Ubi7 SEQ ID NO: 58 and terminator Ubi3 SEQ I D NO: 59.
- This transformation vector will be introduced into an Agrobacterium strain such as LBA4404 or AGL-1 as described in Example 2 above.
- the Agrobacterium strains are used to transform the polynucleotides info a plant, such as a potato plant to confer resistance to PVY.
Abstract
The present invention concerns new compositions and methods for conferring resistance to Potato virus Y (PVY) in plants by expressing nucleotide sequences that share homology to sequences in both PVY and Solanum.
Description
PVY RESISTANCE
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims the benefit of U.S. Provisional Patent Application Serial No.
61/663,467, filed June 22, 2012, and U.S. Provisional Patent Application Serial No. 61/783,342, filed March 14, 2013, both of which are hereby incorporated by reference in their entireties for all purposes.
F!ELD
The present inventive technology relates to the expression of recombined genetic elements from potato plants, e.g., Solatium phureja, and/or recombined genetic elements from Potato Virus Y (PVY) to confer broad-spectrum Potato Virus Y (PVY) resistance to intragenic plants.
BACKGROU D
Potato virus Y (PVY), a member of the family Potyviridae, is a virus that affects potato production worldwide. Necrotic ringspot disease symptoms and reduced tuber yields caused by PVY infection results in substantial production losses. Some PVY resistant and tolerant varieties have been developed through traditional plant breeding, but none of these varieties were widely adopted because they lack important traits required by the industry. Efforts to introgress PVY resistance into the most popular cultivars are complicated by complex autotetrapioid genetics, numerous prezygotic and postzygotsc barriers, and inbreeding depression.
Previous efforts to develop PVY resistance in transgenic potato plants focused on the expression of pathogen-derived sequences, such as the viral coat protein gene (Lawson et al., 1990, Biotechnol J 8:127-134) and the helper component proteases gene (Arif et al., 2011, Transgenic Res 21: 303-11). The permanent introduction of such foreign D!MA in the food supply raises public concerns.
SUSV1SV1ARY
One aspect of the present invention is an isolated polynucleotide comprising multiple plant DNA sequences, wherein each plant DMA sequence shares sequence homology to a corresponding DNA sequence from the genome(s) of at least one strain of Potato Virus Y. In one embodiment, the isolated polynucleotide comprises 2, 3, 4, 5, 6, 7, 8, 9, 10, or more than 10 plant D!MA sequences. In
one embodiment, each plant DNA sequence of the polynucleotide shares at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence homology with a PVY DNA sequence, in one embodiment, the plant DNA sequences are potato plant DNA sequences. In one embodiment, each plant DNA sequence of the polynucleotide shares at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence homology to potato, and is selected from the group consisting of Ranger Russet, Russet Burbank, Atlantic, Phureja and Shepody. In another embodiment, the plant DNA sequences within the polynucleotide are sequences from the genome of the same potato variety. In another
embodiment, the plant DNA sequences within the polynucleotide are sequences from multiple genomes of different potato varieties, in one embodiment, the polynucleotide comprises potato plant DNA sequences selected from one or more of sequences endogenous to Ranger Russet, Russet Burbank, Atlantic, and Shepody potato varieties. In another embodiment the DNA source is a wild potato species such as Solanum phureja, Solanum microdontum, Solanum bulbocastanum, In one- embodiment, the polynucleotide in the vector comprises one or more sequences selected from the group consisting of SEQ ID NOs. 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, and 103.
Another aspect of the present invention is an isolated polynucleotide comprising multiple viral DNA sequences. In one embodiment, each viral DNA sequence is derived from the same and/or different strain of Potato Virus Y, wherein each virai DNA sequence shares high sequence homology to a DNA sequence from the genome(s) of a plant, for example, a potato plant. In one embodiment, each viral DMA sequence of the polynucleotide shares at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more, sequence homology with a plant DNA sequence. In one embodiment, the isolated polynucleotide comprises 2, 3, 4, 5, 6, 7, 8, 9, 10, or more than 10 viral DNA sequences. In another embodiment, the viral DNA sequences share high homology to the DNA sequences from the genome of the same potato variety. In another embodiment, the virai DNA sequences share high homology to sequences from multiple genomes of different potato varieties. In one embodiment, the potato is selected from the group consisting of Ranger Russet, Russet Burbank, Atlantic, Phureja and Shepody. In another embodiment the potato plant is a wild potato species such as Solanum phureja, Solarium microdontum, or Solanum bulbocastanum.
Another aspect of the present invention is an expression vector comprising a promoter operably linked to a polynucleotide comprising multiple plant DNA sequences, wherein each plant
DNA sequence shares sequence homology to a corresponding DNA sequence from the genome(s) of at least one strain of Potato Virus Y. in one embodiment, the polynucleotide in the vector comprises one or more sequences selected from the group consisting of SEQ ID NOs. 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, and 103.
Another aspect of the present invention is an expression vector comprising a promoter operabiy linked to a polynucleotide comprising multiple viral DNA sequences, wherein viral DNA sequence shares high sequence homology to a DNA sequence from the genome(s) of one or more plant species/varieties., such as one or more potato species/varieties. In one embodiment, the polynucleotide in the vector comprises one or more sequences selected from the group consisting of SEQ ID NOs. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 45, 48, 53, and 57.
Another aspect of the present invention is a method for conferring full or partial resistance in a plant to at least one strain of Potato Virus Y infection, comprising expressing in a plant a polynucleotide that comprises multiple plant DNA sequences, wherein each plant DNA sequence shares sequence homolog to a corresponding DNA sequence from the genome(s) of at least one strain of Potato Virus Y, wherein the plant is fully or partially resistant to PVY infection compared to a plant of the same species that does not express the polynucleotide, in one embodiment, the plant is a potato plant. In one embodiment, the potato is selected from the group consisting of Ranger Russet, Russet Burbank, Atlantic, Phureja and Shepody. In another embodiment, the plant DNA sequences within the polynucleotide are sequences from the genome of the same potato variety. In another embodiment, the plant DNA sequences within the polynucleotide are sequences from multiple genomes of different potato varieties. In another embodiment the sequences are from a wild potato species such as Soianum phureja, Soianum microdontum, Solarium buibocastanum. In one embodiment, the polynucleotide comprises potato plant DNA sequences selected from one or more of sequences endogenous to Ranger Russet, Russet Burbank, Atlantic, Shepody potato varieties, or a wild potato species. In one embodiment of this method, the plant DNA sequences are potato plant DNA sequences, in another embodiment of this method., the plant is a potato plant and the plant DNA sequences are potato plant DNA sequences. In one embodiment, the polynucleotide in the vector comprises one or more sequences selected from the group consisting of SEQ ID !MQs, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, and 103.
Another aspect of the present invention is a method for conferring full or partial resistance in a plant to at least one strain of Potato Virus Y infection, comprising expressing in a plant a polynucleotide that comprises multiple viral DNA sequences, wherein each viral DNA sequence shares sequence homology to a DNA sequence from the genome(s) of a plant, wherein the plant is fully or partially resistant to PVY infection compared to a plant of the same species that does not express the polynucleotide. In one embodiment, the plant is a potato plant. In one embodiment, the potato is selected from the group consisting of Ranger Russet, Russet Burbank, Atlantic, Phureja and Shepody. In another embodiment, the viral DNA sequences within the polynucleotide are sequences sharing homology to the genome of the same potato species/variety. In another embodiment, the viral DNA sequences within the polynucleotide are sequences sharing homology to multiple genomes of different potato species/varieties. In another embodiment the sequences share homology to the genome of a wild potato species such as So!anum phureja, Solanum microdontum, Solanum bulbocastanum, In one embodiment, the polynucleotide shares homology to a sequence comprises potato plant DNA sequences selected from one or more of sequences endogenous to Ranger Russet, Russet Burbank, Atlantic, Shepody potato varieties, or a wild potato species, in one embodiment of this method, the plant DNA sequences are potato plant DNA sequences. In one embodiment of this method, the polynucleotide comprises one or more sequences selected from the group consisting of SEQ ID NOs. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 45, 48, 53, and 57.
In one embodiment, a polynucleotide of the present invention comprises at least two sequences selected from the SEQ ID NOs.: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12. In another embodiment, the polynucleotide comprises the sequence of SEQ ID NO: 13.
In one embodiment, a polynucleotide of the present invention comprises at least two sequences selected from the SEQ ID NOs.: 60.. 61, 62.. 63, 64, 65, 66, 67, 68, 69, 70, and 71.
In one embodiment, a polynucleotide of the present invention comprises at least two sequences selected from the SEQ ID NOs.: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, and 25. In another embodiment, the polynucleotide comprises the sequence of SEQ ID NO: 26.
In one embodiment, a polynucleotide of the present invention comprises at least two sequences selected from the SEQ ID NOs.: 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82.. and 83, or at least two sequences selected from the SEQ ID NOs.: 84, 85.86,87, 88, 89, 90, 91, 92, 93, 94, and 95, or at least two sequences selected from the SEQ ID NOs.: 96, 97, 98, 99, 100, 101, 102, and 103. in one
embodiment, a polynucleotide of the present invention comprises at least two sequences selected from the SEQ I D NOs. : 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, and 38. In another em bodiment, the polynucleotide comprises the sequence of SEQ I D NO: 39.
In one em bodiment, a polynucleotide of the present invention comprises at least two sequences selected from the SEQ I D NQs,: 45, 48, 53, and 57. In a nother em bodiment, the polynucleotide comprises the sequence of SEQ I D NO: 58.
In one em bodiment, a polynucleotide of the present invention comprises one or more sequences selected from the group consisting of: (1) complements of a sequence of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 45, 48, 53, and 57; (2) reverse complements of a sequence of 1, 2, 3, 4, 5, 6, 7. 8, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 45, 48, 53, and 57; (3) reverse sequences a sequence oil, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 45, 48, 53, and 57; (4) a portion of a nucleotide sequence comprising at least 15. 16, 17, 18, 19, 20, or 21 contiguous nucleotides of a nucleotide sequence selected from the group consisting of a nucleotide sequence recited in (1) -(3);
(5) a nucleotide sequence having at least 95% identity to a nucleotide sequence recited in (1) ~-{3);
(6) a nucleotide sequence having an E value of 0,01 when aligned with a sequence recited in (1) -(3); and (7) a nucleotide sequences that hybridize to a sequence recited in (1) -(3) under stringent conditions, wherein said stringent conditions are hybridization in 0.25 M a2H P04 buffer (pH 7.2} containing 1 mM IMa2EDTA, 20% sodium dodecyi sulfate at 45°C, followed by a wash in SxSSC, containing 0.1% (w/v) sodium dodecyi sulfate, at 55°C to 65°C.
In one em bodiment, a polynucleotide of the present invention comprises one or more sequences selected from the group consisting of: (1) complements of a sequence of SEQ ID NOs: 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, and 103; (2) reverse complements of a sequence of 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, and 103; (3) reverse sequences a sequence of 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, and 103; (4) a portion of a nucleotide sequence comprising at least 15, 16, 17, 18, 19, 20, or 21 contiguous nucleotides of a nucleotide sequence selected from the group consisting of a nucleotide sequence recited in (1) -(3); (5) a nucleotide sequence having at least 95% identity to a nucleotide sequence
recited in (1) -(3); (6) a nucleotide sequence having an E value of 0.01 when aligned with a sequence recited in (1) -(3); and (7) a nucleotide sequence that hybridizes to a sequence recited in (1) -(3) under stringent conditions, wherein said stringent conditions are hybridization in 0.25 M Na2HP04 buffer (pH 7.2} containing 1 mM a2EDTA, 20% sodium dodecyl sulfate at 45°C, followed by a wash in 5xSSC, containing 0.1% (w/v) sodium dodecyl sulfate, at 55°C to 65°C.
In one embodiment, a polynucleotide of the present invention comprises (1) one or more plant DNA sequence, wherein each plant DNA sequence shares sequence homology to a
corresponding DNA sequence from the genome(s) of at least one strain of a virus, such as Potato Virus Y; and (2) one or more viral DNA sequences, wherein each viral DNA sequence shares sequence homology to a corresponding DNA sequence from the genome(s) of at least one plant, such as a potato plant. In one embodiment, each plant DNA sequence shares at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more sequence homology with a PVY DNA sequence. In one embodiment, the polynucleotide comprises at least one sequence selected from SEQ ID NOs.: 60-83, or reverse complements thereof. In one embodiment, each viral DNA sequence shares at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more sequence homology with a potato plant DNA sequence. In one embodiment, the polynucleotide comprises at least one sequence selected from SEQ ID Qs. 1-38, 45, 48, 53, 57, and 58, or reverse complements thereof.
The present invention also provides expression vectors. In one embodiment, an expression vector of the present invention comprises a polynucleotide described herein.
The present invention also provides transgenic cells comprising a polynucleotide described herein, or organisms comprising said transgenic cells. In one embodiment, provided are transgenic plants, plant parts, or plant ceils. Also provided are methods of making and using said transgenic plants, plant parts, or plant ceils, in one embodiment, the plant parts include potato tubers or microtubers.
In one embodiment, seeds of the transgenic plants are provided, wherein said seed comprises said isolated polynucleotide.
In one embodiment, progeny plants of the transgenic plants are provided, wherein the progeny plants have an altered pathogen tolerance and/or resistance as a result of inheriting the polynucleotide.
The present invention also provides methods for producing hybrid seeds, in one
embodiment, the methods comprise crossing at least one transgenic plant or a progeny plant of the present invention with a second plant. In one embodiment, the second plant is a different plant of the same species, or a related species, in one embodiment, the second plant is a different plant of the same variety, or a different variety, in one embodiment, the methods comprise harvesting the resultant seed.
The present invention also provides methods for producing a plant having altered pathogen tolerance and/or resistance. In one embodiment, the methods comprise transforming a plant cell with an expression vector to provide a transgenic ceil. In one embodiment, the expression vector comprises: (i) a promoter sequence; (ii) an isolated polynucleotide sequence of the present invention; and (iii) a gene termination sequence, in one embodiment, the methods further comprise cultivating the transgenic cell under conditions conducive to regeneration and mature plant growth of a plant having altered pathogen tolerance and/or resistance.
The present invention also provides methods for modifying a phenotype of a target organism, in one embodiment, the methods comprise stably incorporating into the genome of the target organism a genetic construct. In one embodiment, the genetic construct comprises: (a) a promoter sequence; (b) an isolated polynucleotide sequence of the present invention; and (c) a gene termination sequence. In one embodiment, the target organism is a plant.
The present invention also provides processes of determining the presence or absence of an isolated polynucleotide sequence of the present invention, or fragments and variations thereof in a plant, in one embodiment, the processes are based on DMA hybridization, RNA hybridization, and/or protein hybridization. In one embodiment, the processes comprise at least one of: (a) isolating nucleic acid molecules from said plant and amplifying sequences homologous to the polynucleotide; (b) isolating nucleic acid molecules from said plant and performing a hybridization to detect the polynucleotide; and (c) demonstrating the presence of mRNA sequences derived from a polynucleotide mRNA transcript and unique to the polynucleotide.
The present invention also provides methods for breeding plants to produce altered pathogen tolerance and/or resistance. In one embodiment, the methods comprise making a cross between a first plant with an isolated polynucleotide sequence of the present invention with a second plant to produce a Fl plant, in one embodiment, the methods further comprise backcrossing the Fl plant to the second plant. Still in one embodiment, the methods further comprise repeating the backcrossing step to generate a near isogenic or isogenic line, wherein the isolated
polynucleotide sequence of the present invention is integrated into the genome of the second plant and the near isogenic or isogenic line derived from the second plant with the isolated polynucleotide sequence has conferred or enhanced pathogen tolerance and/or resistance compared to that of the second plant without the isolated polynucleotide sequence.
DETA!LED DESC !PT!O
A new approach for conferring resistance to Potato virus Y (PVY) in plants is described herein and is based upon the expression of nucleotide sequences that are endogenous to the genomes of both PVY and species of Solanum. Genetically engineered plants that are resistant to PVY and which express polynucleotides obtained from within the plant's own gene pool, as is the case for conventional plant breeding are highly desirable (Rommens CM, Haring MA, Swords K, Davies HV, Belknap WR (2007) The intragenic approach as a new extension to traditional plant breeding. Trends Plant Sci 12: 397-403, which is incorporated herein by reference in its entirety).
According to the present invention, therefore, multiple discontiguous regions of intergenic and/or intragenic DNA from the wild potato species Solanum phureja are recombined, operably linked to a promoter and terminator, and transformed into a cultivated plant susceptible to potato virus Y (PVY). in one embodiment, the promoter is selected from the group consisting of constitutive promoters, non-constitutive promoters, inducible promoters, tissue-specific promoters, and developmental stage-specific promoters. In one embodiment, the tissue-specific promoter is a leaf- specific promoter or a shoot-specific promoter, such as the promoters associated with ribulose 1,5- bisphosphate carboxylase (RUBISCO), chlorophyll A/B binding protein (CAB), rubisco activase (RA), early light inducible protein (EL!P), glyoxysomal maiate dehydrogenase (gMDH), and those described in U.S. Pat, No. 7534934 and U.S. Pat, Appl. Pub!. Nos. 20080301837 and 20090220670, each of which is incorporated by reference in its entirety. In one embodiment, the tissue-specific promoter does not drive gene expression in the tuber.
Alternatively, another way to introduce resistance to virus into plants while reducing the public concerns of permanent introduction of foreign DNA into plants is to use viral sequences which share high homology to plant genome sequences. Due to the high homology to plant genome sequences, such viral sequences are more likely to be deemed safe and therefore be perceived as being more acceptable to the public. Therefore, multiple discontiguous regions of DNA from a virus that share high homology to the DNA of potato plants, such as the wild potato species Solanum
phureja can be recombined, operabiy linked to a promoter and terminator, and transformed into a cultivated plant susceptible to potato virus Y (PVY). In one embodiment, the promoter is selected from the group consisting of constitutive promoters, non-constitutive promoters, inducible promoters, tissue-specific promoters, and developmental stage-specific promoters. In one embodiment, the tissue-specific promoter is a leaf-specific promoter or a shoot-specific promoter, such as the promoters associated with ribuiose 1,5-bisphosphate carboxylase (RUBISCO), chlorophyll A/B binding protein (CAB), rubisco activase (RA), early light inducible protein (BLIP), giyoxysomal malate dehydrogenase (gMDH), and those described in U.S. Pat. No. 7534934 and U.S. Pat. Appl. Publ. Nos. 20080301837 and 20090220670, each of which is incorporated by reference in its entirety. In one embodiment, the tissue-specific promoter does not drive gene expression in the tuber.
Expression of the cassette into plants results in the production of RNA transcripts that target the PVY genome for degradation through various mechanisms, such as RNA interference. The development of PVY resistance through expression of several discontiguous endogenous DNA elements as single DNA element to target multiple and specific regions of a viral polyribonucleotide while reducing the public's concern of permanent introduction of foreign DNA in to plants is a novel and inventive approach to conferring PVY resistance to a plant.Accordingiy, the present invention encompasses methods for identifying in a plant genome endogenous one or more nucleotide sequences that share sequence identity with a corresponding sequence or sequences endogenous to the PVY genome. Alternatively, the present invention encompasses methods for identifying one or more viral genome nucleotide sequences that share high (e.g., >90%) or very high (e.g., >95%) homology with a sequence or sequences endogenous to the plant genome. One way this can be done is by aligning pu blicly available PVY sequences against plant DNA databases, such as GenBank. The alignment can then be analyzed for regions of conservation among the aligned sequences. The genome sequence information of potato species, such as S. tuberosum and 5. phureja, is publicly available and can be obtained through the Potato Genome Sequencing Consortium database. The tomato genome sequence is recently released by the Tomato Genome Consortium (Nature, 2012, 485:635-641). The genome sequence information for PVY is described in Thole et al. (Gene, Volume 123, Issue 2, 30 January 1993, Pages 149-156), Robaglia et al. (J. gen. Virol. 1989, 70:935-947), and Lorenzen et al. (Arch. Virol. 2006, 151:1055-1074), each of which is incorporated by reference in its entirety.
In one embodiment, the endogenous nucleotide sequences in the plant genome are intergenic sequences, in one embodiment, the intergenic sequences do not encode any functional
polypeptides. In some embodiments, the endogenous nucleotide sequences in the plant genome are intragenic sequences (e.g., cis-elements, exons, introns, 5' or 3' terminal sequences). In some embodiments, the endogenous nucleotide sequences in the plant genome encode functional polypeptides which when suppressed do not bring any undesired plant phenotypes.
Regions of high genetic conservation among PVY strains can also be searched for PVY sub- regions of high homology, e.g., greater than, for instance, at least 90% homology., to the sequenced and publicly available plant genome, such as to the Solanum Phureja genome provided by the Potato Genome Sequence Consortium. The skilled person knows that alignment programs such as those provided by the NCBI BLAST analysis, is useful in this regard. These highly identical PVY su b-regions can then be analyzed for homology with potato cDNAs, and desired sequences sharing homology to any cDNA can be identified and prioritized.
These prioritized sequences therefore are sequences that are highly identical to sequences represented by the genomes of the various PVY strains, and also highly (e.g., >90%) or very highly (e.g., >95%) identical to sequences represented by the genomes of the various plant
species/varieties. In one aspect of the present invention, one or more of these sequences can be used in an expression vector. In one embodiment, two or more expression vectors each comprising at least one of the prioritized sequences can be introduced into a plant. In one embodiment, a binary vector system is used, such as those described in U.S. Pat. No, 7923600, which is incorporated by reference in its entirety.
In one aspect of the present invention, two or more of these sequences can be joined together to yield a single polynucleotide within which two or more plant-derived, PVY-homo!ogous sub-sequences, or two or more virus-derived, plant homologous sub-sequences, or at least one plant-derived, PVY-homologous sub-sequence and at least one virus-derived, plant homologous subsequence. Accordingly, in one polynucleotide there may be sequences derived from plants that are identical to, or highly or very highly homologous to, sequences present in one or more strains of PVY. Alternatively, in one polynucleotide there may be sequences derived from virus that are identical to, or highly or very highly homologous to, sequences present in one or more plant species/varieties. In other embodiments, in one polynucleotide there may be sequences derived from plants that are identical to, or highly or very highly homologous to, sequences present in one or more strains of PVY, and sequences derived from virus that are identical to, or highly or very highly- homologous to, sequences present in one or more plant species/varieties.
In one embodiment, the two or more sequences can be joined together in any order, in any way, by any method as suitable. In one embodiment, one or more copies of each sequence are joined, in one embodiment, each sequence is directly joined. In one embodiment, an "insulator" sequence is included between the joined sequences, in one embodiment, the "insulator" sequence does not share any homology or very little homology to any sequence of the plant and/or PVY. In one embodiment, the single polynucleotide produces at least one interference RNA against PVY when transcribed. In one embodiment, the single polynucleotide comprises one or more inverted repeats, antisertses, and/or hairpin structures.
"Resistance": a resistant plant is able to limit PVY proliferation and/or PVY-caused disease symptom development when compared to a plant that is not resistant. Thus, "resistance" is a relative concept. The transgenic resistant plants described in this invention are able to limit PVY proliferation and/or PVY-caused disease symptom development compared to their untransformed counterparts. For example, the plants show no symptoms or show some symptoms but that are still able to produce marketable product with an acceptable yield. As defined by the Internationa! Seed Federation (ISF), the recognition of whether a plant is affected by or subject to a pest or pathogen can depend on the analytical method employed. Resistant plant types may still exhibit some disease symptoms or damage. The resistance can be either high (e.g., the growth and development of the specified pest or pathogen is highly restricted under normal pest or pathogen pressure when compared to susceptible varieties), or moderate/intermediate (e.g., the growth and development of the specified pest or pathogen is restricted, but the plants exhibit a greater range of symptoms or damage compared to plant types with high resistance). A plant is resistant to the virus strain if it has a virus RNA and/or protein density that is about 50%, about 40%, about 30%, about 20%, about 10%, about 5%, about 2%, about 1%, about 0.1%, about 0.01%, about 0.001%, or about 0.0001% of the RNA and/or protein density in a control plant.
The term "full resistance" in the context of the present invention means that, after being infected with the PVY virus, no viral proliferation is detected and/or no PVY-caused symptoms are observed the entire length of an experiment., which is usually 2-4 weeks.
The term "partial resistance" in the context of the present invention means that, the plants have reduced multiplication of the virus in the cell, as reduced (systemic) movement of the virus, and/or as reduced symptom development after infection compared to susceptible plants. The resistance is often referred to as "intermediate resistance".
The term "delayed disease progression" or "delayed disease symptoms" or "to resist the onset of one or more symptoms of PVY disease," or "partial resistance" in the context of the present invention means that PVY proliferation and/or PVY-caused disease symptom development is limited in a plant compared to another plant, whereby limited should be interpreted here to mean that PVY proliferation and/or PVY-caused disease symptom development is not fully prevented. For example, the transformed plant may display disease symptoms 1-3 days, 3-5 days, 5-7 days, 7-9 days, 9-11 days, 11-13 days, 13-15 days, 2-3 weeks, 3-4 weeks, 4-5 weeks, 5-7 weeks, 7-10 weeks, 2-3 months and 3-5 months later than the untransformed plant. Transformed plants with delayed disease progression typically carry the PVY virus protein upon infection. The PVY virus protein can be detected via ELISA assay. The length of the symptom delay varies.
Orthologs and paralogs of the sequences disclosed herein are also part of the invention. The term "ortholog" refers to genes in different species that evolved from a common ancestral gene by speciation. Normally, orthologs retain the same function in the course of evolution. Identification of orthologs is critical for reliable prediction of gene function in newly sequenced genomes. The term "paralog" refers to genes related by duplication within a genome. While orthologs generally retain the same function in the course of evolution, paralogs can evolve new functions, even if these are related to the original one.
PVY: Potato virus Y (PVY) is one of the most prevalent and important viruses in potatoes. Recently, strains of PVY which can cause necrosis (dead spots on leaves and in tubers) have been discovered, creating more concern about this widespread virus. PVY is a Potyvirus, the type member of the largest group of plant viruses. It is transmitted by aphids in a nonpersistent manner, by sticking to aphid mouthparts (stylet). The virus can be acquired from the infected plant within seconds, and transmitted to a healthy plant just as fast. PVY can also be transmitted mechanically by machinery, tools., and damaging plants while walking through the field. Aphids are by far the most efficient means of transmission. Several strains of PVY have been identified that differ by the symptoms they cause in potatoes and tobacco. PVY0 is the common strain, and causes mosaic symptoms. PVY1' causes stipple streak. PVYN, the necrotic strain, generally causes mild foliage symptoms, but necrosis in the leaves of susceptible potato varieties. Mixed infections of common strains and the necrotic strain are common, and the genomes (genetic material) can mix, producing hybrid strains (i.e. PVYN:i!> and PVYrJ N). PVYrJ N strains can cause tuber necrosis, and are of increasing importance in New York. Diagnosis can be difficult, because there are antibodies to PVY0 and PVYr\ but immunological methods (ELISA, Enzyme Linked Immunosorbent Assay) cannot distinguish PVYN : ] from these two virus strains.
Examples of PVY sequences are provided in GenBank accession numbers: X97895, X12456, M95491 D00441, U09509, NC_001616, JN034046, JF928460, JF928459, JF928458, JF795485, HQ912915, HQ912914, HQ912913, HQ912912, HQ912911, HQ912910, HQ912909, HQ912908, HQ912907, HQ912906, HQ912905, HQ912904, HQ912903, HQ912902, HQ912901, HQ912900, HQ912899, HQ912898, HQ912897, HQ912896, HQ912895, HQ912S94, HQ912893, HQ912892, HQ912891, HQ912890, HQ912889, HQ912888, HQ912887,. HQ912886, HQ912SS5, HQ912884, HQ912883, HQ912882, HQ912881, HQ912880, HQ912879, HQ912S78, HQ912877, HQ912876, HQ912875, HQ912874, HQ912873, HQ912872, HQ912871, HQ912870, HQ912S69, HQ912868, HQ912867, HQ912866, HQ912865, HQ912864, HQ912863, HQ912S62, HQ631374, H 991454, HM 991453, HM59Q407, H 590406.. HM590405, HM 367076, HM367075, GQ200836, FJ666337, FJ643479, FJ643478, FJ643477, FJ214726, FJ204166, FJ204165, FJ204164, EU563512, EU482153, EU182576, EF558545, EF026076, EF026075, EF026074, EF016294, DQ309028, DQ157180,
DQ157179, DQ157178, DQ008213, AY884985, AY884984, AY884983, AY884982, AY745492, AY745491, AY166867, AY166866, A 268435, AM113988, AJ890350, AJ890349, AJ890348,
AJ890347, AJ890346, AJ890345, AJ890344, AJ890343, AJ890342, AJ889868, AJ889867, AJ889866, AJ585342, AJ585198, AJ585197, AJ585196, AJ585195, AJ584851, AJ439545, AJ439544, AF522296, AF463399, AF237963, AB461454, AB461453.. AB461452, AB461451, AB461450, AB331519,
AB331518, AB331517, AB331516, AB331515, AB270705, AB185833, A08776
The polynucleotides of the present invention can be introduced into a plant by any suitable method, such as Acjro bacterium-mediated transformation, viral infection, whiskers, eiectroporation, microinjection, polyethylene g!ycol-treatmertt, heat shock, iipofection and particle bombardment. "Transformation" of a plant is a process by which DMA is stably integrated into the genome of a plant ceil. "Stably" refers to the permanent, or non-transient retention and/or expression of a polynucleotide in and by a cell genome. Thus, a stably integrated polynucleotide is one that is a fixture within a transformed cell genome and can be replicated and propagated through successive progeny of the cell or resultant transformed plant. Transformation may occur under natural or artificial conditions using various methods well known in the art. See, for instance, METHODS IN PLANT MOLECULAR BIOLOGY AND BIOTECHNOLOGY, Bernard R. Giick and John E. Thompson (eds), CRC Press, inc., London (1993); Chilton, Scientific American, 248) (6), pp. 36-45, 1983; Bevan, Nucl. Acids. Res., 12, pp. 8711-8721, 1984; and Van Montague et al., Proc R Soc Lond B Biol Set., 210 (1180), p. 351-65, 1980. Plants also may be transformed using "Refined Transformation" and "Precise Breeding" techniques. See, for instance, Rommens et al. in New Zealand Patent 535,395, U.S. Pat. No. 7,250,554, U.S. Pat. No. 7,534,934, WO2005/004585, U.S. Pat. No. 7,598,430, US-2005-
0034188, US-2012-01Q25S9, WO2QQ5/Q02994, and New Zealand Patent 536,037, which are ail incorporated herein by reference.
Any method suitable for gene silencing in plants can be used. Non-limiting examples of gene silencing methods in plants are described in U.S. Patent Nos. 8058509, 7320892, 7754697, 7417180, 7816581, 7902425, 8395023, 7807880, 8362323, 8293977, and 7928289; U.S. Patent Application Publication Nos. 20070011775, 20070298481, 20120246765, 20070220628, 20100199386, 20050214263, 20100058490, and 20070118918; Meyer 2011 (Gene Silencing in Higher Plants and Related Phenomena in Other Eukaryotes, Springer London, Limited, 2011, ISBN 3642791476, 9783642791475), Oksman-Caldente (Plant Biotechnology and Transgenic Plants, CRC Press, 2002, ISBN 0824743784, 9780824743789), and Doran and Helliwell (RNA Interference: Methods for Plants and Animals, CABI, 2009, ISBN 1845934105, 9781845934101 }, each of which is herein incorporated by reference in its entirety for all purposes. In one embodiment, a silencing vector comprises two or more promoters which flank one or more desired polynucleotides or which flank copies of a desired polynucleotide, such that both strands of the desired polynucleotide are transcribed. That is, one promoter may be oriented to initiate transcription of the 5'-end of a desired polynucleotide, while a second promoter may be operably oriented to initiate transcription from the 3'-end of the same desired polynucleotide. The oppositely-oriented promoters may flank multiple copies of the desired polynucleotide, as described in U.S. Patent Nos. 7713735 and 8158414, each of which is herein incorporated by reference in its entirety for all purposes.
Also provided are methods for identifying plants comprising one or more polynucleotides of the present invention. In one embodiment, the identification is based on detecting the presence or absence of any fragment of the transgene described herein, such as the promoter sequence, the termination sequence, the selection marker, or the polynucleotide sequence having similarity to the PVY sequence. For example, methods based on DNA hybridization (e.g., PGR, Southern blot) can be used. In one embodiment, the identification is based on detecting the presence or absence of any RNA transcript encoded by the transgene described herein. For example, methods based on RNA hybridization (e.g., RT-PCR, Northern blot) can be used. In one embodiment, the identification is based on detecting the presence or absence of resistance to PVY. In one embodiment, two or more methods described above are combined.
Also provided are methods for making and using the plants comprising one or more polynucleotides of the present invention. In one embodiment, classic breeding methods can be included in the present invention to introduce one or more recombinant genes of the present invention into other plant varieties, or other close-related species that are compatible to be crossed
with the transgenic plants of the present invention. Such techniques include, but are not limited to, Open-Pollinated Populations, Mass Selection, Synthetics, Pedigreed varieties, and Hybrids.
Additional breeding methods have been known to one of ordinary skill in the art, e.g., methods discussed in Chahal and Gosai (Principles and procedures of plant breeding: biotechnological and conventional approaches, CRC Press, 2002, ISBN 084931321X, 9780849313219), Taji et al. (In vitro plant breeding, Routledge, 2002, ISBN 156022908X, 9781560229087), Richards (Plant breeding systems, Taylor & Francis US, 1997, ISBN 0412574500, 9780412574504), and Hayes (Methods of Plant Breeding, Publisher: READ BOOKS, 2007, ISBN1406737062, 9781406737066), each of which is incorporated by reference in its entirety.
This invention is further illustrated by the following examples which should not be construed as limiting. The contents of all references, patents and published patent applications cited throughout this application, as well as the Figures and the Sequence Listing, are incorporated herein by reference.
Example 1
PVY Target Identification and Organization
A potato derived sequence for broad-spectrum PVY control was defined as follows:
1. Full-genome Potato Virus Y (PVY) sequences that are publicly available at GenBank (141 accessions) were aligned using BLAST analyses and other common methods known to those skilled in the art.
2. The alignment was analyzed for candidate conserved regions.
3. The identified regions were validated and ranked for broad-spectrum sequence conservation against a pool of 800+ partial PVY sequence accessions.
A. Regions of high genetic conservation among PVY strains were searched for sub- regions with > 90% homology to the sequenced and publicly available Soianum Phureja genome sequence by BLAST analysis.
5. These sub-regions were analyzed for homology with potato cDNAs, and sequences with < 80% homology to any cDNA were prioritized.
6. The prioritized genetic elements, which were highly conserved to both the PVY genetic spectrum and potato intergenic sequence were then joined, yielding a "425bp molecule comprised of 12 genetic elements.
7. The junctions of flanking potato DMA elements were engineered to share a short region of overlapping homology to PVY sequence. For example, the first 5bp of the potato DMA comprising SEQ ID NO: 3 shares perfect homology to the 5bp of PVY sequence beyond the target region of SEQ ID NO:2.
Alternatively, after step 5 above, one or more plant derived sequences that share high or very high homology to the virus-derived sub-regions can be joined. Such joined sequences can be used to introduce PVY resistance into plants as well.
Exemplary sequences derived from PVY or plants that can be used to introduce PVY resistance into plants are shown in the table below.
S.phujera
SEQ Homology to PVY S, js ureja SEQ
Sequences in pS!M2201 genome Start Stop Sequence in S. phurejQ
SD (%) Chromosome SD homology (%)
1 CATCCATCATAACCCAAACTC 100% 90.5 c: 5562979 5562998 CATCCATCATAACC-AATCTC 60
2 CGTTGATGTTTGGCGAGGTT 100% 90.0 12 34296651 34296632 CGTTGATGTGGGGCGAGGTT 61
3 CCATTTTCAATGCACCAAACCA 100% 90.9 a 38265887 38265866 CCA I i ! I l AA ! GCAC I AAACCA 62
4 TAAGCCCATTCATCACAGTT 100% 90.0 6 7383439 7383420 TAAGCCCATTCATGACGGTT 63
5 G G G CTG ATTTC A ATG CTG CG 100% 90.0 2 52886128 52886109 GGG CTC ATTTCAATG ATG CG 64
6 GCCTTCATTTGAATGTGCGCTT 100% 90.9 4 42796985 42796965 G C CTTC ATTTG A ATTTG - G CTT 65
ATTTGTTTAATTCTTGAACTTCAA
ATTTGTTTAATTCTTGAACTTCAAGTA GTACTCACACTCCACCACATAAAC CTCACACTCCACCACATAAACCCCCAA CCCCAAGGGTGGACCAACTGTTT
175 first nuc!. = 100% GGGTGGACCAACTGTTTACCAAAACA ACCAAAACAACACATCCCTTTATG
horn to 5. phujera; ACACATCCCTTTATGTATTTTTCAATC TATTTTTCAATCAAATAGTTTGTT 99.0 42796790 42796985 66 last 22 nuci. = 100% AAATAGTTTGTTGTTTCATCAACTTTC GTTTCATCAACTTTCTAATCTTCAA
to PVY TAATCTTC AATAC AG G ATG ACTCCAA TACAGGATGACTCCAATACATCA TACATCAGTTGCCTAaagc- GTTGCCTAAAGCGCACATTCAAAT
caaattcaaatgaaggc
GAAGGC
8 CGCAGCATTGAAATCAGCCC 100% 90.0 52886109 52886128 CG CATCATTG AAATG AG CCC 67
9 AACTGTGATGAATGGGCTTA 100% 90.0 6 7383420 7383439 AACCGTC ATG AATG G G CTTA 68
10 TG GTTTG GTG CATTG AAAATG G 100%. 90.9 3 38265866 38265887 TG GTTTAGTG CATTA AAAATG G 69
1 AACCTCG CCAAACATCAACG 100%, 90.0 12 34296632 34296651 AACCTCGCCCCACATCAACG 70
12 GAGTTTGGGTTATGATGGATG 100% 90.5 5562998 5562979 GAGATT-GGTTATGATGGATG 71
13 Elements [1-12]
S.phujer
SEQ Homology to PVY S. phureja SEQ
Sequences in pS!M2202 genome Start Stop Sequence in S. phurej
!D (*) Chromosome !D homology {%}
14 AGTGATAGAGCGTTTTGCTCTGT 100% 91.3 1 15757842 15757821 AGTGA-AGAGGGTTTTGCTCTGT 72
15 ATG AGTACC ATGTTG C G 100% 94.1 7 5866954 5866938 ATG AG G AC C ATG TTG C G 73
16 CATTTCTATATACGCTTCTG 100%. 95.0 11 15720258 15720239 C ATTTCTATATATG CTTCTG 74
17 CAACATCTGAGAAATGTGCCAT 100%. 90.9 2 56165745 56165725 CAA-ATCTGAGAAATGTGTCAT 75
18 CAACCTTTGTGACCATCAT 100% 94.7 7 28428553 28428570 CAA-CTTTGTGACCATCAT 76
19 ATTCTTGTCTGTTAG G AG CTT 100% 90.5 10 42302832 42302813 ATT-TTATCTGTTAGGAG CTT 77
AATGTTCCTTGTAGAATGAAAGG
AATGTTCCTTGTAGAATGAAAGGGAA G AA AG AAATTTAAAAATAG G G CC AG AAATTTAAAAATAG GGCCGGGCC GGGCCTTGAAACGCTGCCTACGT
175 first nuci. = 100% TTGAAACGCTGCCTACGTATCTCCCA ATCTCCCAAGGAGAAATCAGGCC
horn to S. phujera; AGGAGAAATCAGGCCCTACGTAGTTC CTACGTAGTTCG A ATACAA AG G A 99.0 10 42302638 42302832 8 last 21 nuci. = 100% G AATAC AAAG G AAATTTTCATTTTCG AATTTTCATTTTCGTTCATTCATTT TTCATTCATTTCTGGTGATTACAAGGA CTGGTGATTACAAGGAAAGTGAA AAGTGAAAAACAGACAATAaagctccta AAACAG ACAATAAAG CTCCTAAC
acagataa-aat
AGACAAGAAT
21 ATGATG GTCACAAAG GTTG 100% 94.7 28428570 28428553 ATGATGGTCACAAAG-TTG 79
22 ATGGCACATTTCTCAGATGTTG 100% 90.9 56165725 56165745 ATG AC AC ATTTCTCAG AT -TTG 80
23 CAGAAGCGTATATAGAAATG 100% 95.0 1 15720239 15720258 CAGAAGCATATATAGAAATG 81
24 CG C AAC ATG GTACTC AT 100% 94.1 7 5866938 5866954 CG C AAC ATG GTCCTCAT 82
25 ACAGAGCAAAACGCTCTATCACT 100%, 91.3 1 15757821 15757842 ACAGAGCAAAACCCTCT-TCACT 83
26 Elements [14-25]
S. phujera
SEQ Homology to PVY S. phureja SEQ
Sequences in Vector pS!M2203 genome Start Stop Sequence in 5. phureja
!D (%) Chromosome !D homology {%}
27 TATATATCGTCCGGAGAGACAC 100% 90.9 12 37486531 37486552 TACATATCGTCGGGAGAGACAC 84
28 TACATCACATGTTCTTGACTC 100% 90.5 1 29931323 29931304 TAC-TCACATGTTCTTGATTC 85
AATGTAC-
29 100%, 96 4 34983808 34983784 AATGTACTTCATCCCATGTG AAATC 86 TCATCCCATGTG AAATC
30 GCGTTCAAGTTTGCGC 100% 93.7 5 35308576 35308591 GCGTTCAAGTTTGTGC 87
31 A G ATTTC G A ATT A A ACC AT ATC 100% 86.4 11 39303698 39303677 AG ATTTCG AACTTA ACC AAATC 88
32 GTG G CAT AT ATG G TTC CTT 100% 94.7 8 15219778 15219796 GTG G C ATATATG GTG CCTT 89
TCATTAAAGGATGTACCACAGAG
TCATTAAAGGATGTACCACAGAGTAT TATG C ATC AGTACTTG G AATGTAC GCATCAGTACTTGGAATGTACTGAGC TGAGCATACAGGATATAGATATT
175 first nuci, = 100% ATAC AG G AT ATA G ATATT A AG CTG A A A AG CTG AACA AATATATATAAG C
horn to 5. phujera; C AAATATATATAAG CTAAAC AAAATA TAAACAAAATATAATTGAGCAAT 99.5 15219971 15219778 90 iast 19 nuci. = 100% TAATTGAGCAATGACATAATGACACG GACATAATGACACGACCCAGGGG
to PVY AC CC AG G G GTACACCATAG ATGTAAC TACACCATAG ATGTAACAAG G CA AAGGCACATAGAACCTCGAaaggcacc CATAGAACCTCGAAAGGAACCAT
atatatgccac
ATATGCCAC
34 GATATGGTTTAATTCGAAATCT 96% 86.4 11 39303677 39303698 GATTTG GTTAAGTTCG AAATCT 1
35 G C G C A A A CTTG A AC G C 100% 93.7 5 35308591 35308576 GCACAAACTTGAACGC 92
GATTTCACATGGGATGA-
36 100% 96 4 34983784 34983808 GATTTCACATGGGATGAAGTACATT 93
GTACATT
37 GAGTCAAGAACATGTGATGTA 100% 90.5 1 29931304 29931323 GAATCAAGAACATGTGA-GTA 94
38 GTGTCTCTCCGGACGATATATA 100% 90.9 12 37486552 37486531 GTGTCTCTCCCGACGATATGTA 95
39 [Elements 27-38]
S.phujera
SEQ Homology to PVY S, js ureja SEQ
Sequences in Vector pSiM2204 genome Start Stop Sequence in S, phureja
\ΰ (%) Chr. iD homology (%)
40 TTAACATGAAGTGATGAAGA NA 100 12 64851983 64851964
TCATG G CATATTAATG GTTG CAAA
41 NA 100 12 64851942 64851896
A A CT A TG C C A AATG ATATG AT G A
42 AATTCATAACTACACAATT NA 100 12 64851874 64851856
43 TGGTTTGGTG CATTG AAAATT 95.2 90.5 11 27434679 27434699 TG GTTTG GTG CATTAA AAATA 96
44 TATTTTCAATGCACCAAACCA 95.2 95.2 11 27434699 27434679 TATTTTTAATG C ACC AAACC A 97
45 [Elements 40,43,41,44,42]
46 C ! GA I G ! 1 1 A l CA i CAAGCA 100 90.5 4 20942557 20942537 CTG AGTGTTTATC AG CTAG C A 98 7 TGCTTGATGATAAACACTCAG 100 90.5 4 20942537 20942557 TGCTAGCTGATAAACACTCAG 99
48 [Elements 40,46,41,47,42]
49 TTAACATGAAGTGATGAAGAT NA 100 12 64851983 64851963
50 AAATTCATAACTACACAATT NA 100 12 64851875 64851856
51 TTCTATATACGCTTCTGCAA 100 90.9 9 29947442 29947461 TTCTATATACGCTGCTGGAA 100
52 TTGCAGAAGCGTATATAGAA 100 90.9 9 29947461 29947442 TTCCAGCAGCGTATATAGAA 101
53 [Element 49,51,41,51,50]
54 GTGTGTCAGGCAATAATTTTT 95.2 90.5 31054475 31054456 ATGTGTCAGGAAATAATTTTA 102
55 TAAAATTATTGCCTGACACAC 100 90.5 5 31054456 31054475 TAAAATTATTTCCTG AC ACAT 103
56 [Elements 40, 54, 41, 55, 42]
57 [Elements 45,48,53, 56]
Citation for elements 40,41,42,49, and 50: Zhang W, Luo Y, Gong X, Zeng W, Li S. "Computational identification of 48 potato microRNAs and their targets." Comput Bio! Chem. 2009 Feb;33(l):84-93. Epub 2008 Jul 15.; Yang , Liu X, Zhang J, Feng J, Li C, Chen J. "Prediction and validation of conservative microRNAs of Solanum tuberosum L." ol Biol Rep. 2010 Oct;37{7):3081-7. Epub 2009 Oct 31.; Xie F, Frazier TP, Zhang B. "identification, characterization and expression analysis of MicroRNAs and their targets in the potato (Solanum tuberosum)." Gene. 2011 Feb 15;473(l):8-22. Epub 2010 Oct 7.
HA: Not Applicable
Example 2
In one embodiment, polynucleotide SEQ ID NO: 13, comprising SEQ ID NO: 1-12, is operabiy linked to promoter Ubi7 SEQ ID NO: 58 and terminator Ubi3 SEQ ID NO: 59, The resulting expression cassette is positioned within a T-DNA region of a binary vector to produce pSIM2201. This
transformation vector will be introduced into an Agrobacterium strain such as LBA4404 or AGL-1 as follows.
Competent LB4404 ceils (50 μ!_) are incubated for 5 min on ice in the presence of l,ug of vector DNA, frozen for about 15 s in liquid nitrogen, and incubated at 37°C for 5 min. After adding 1 ml. of liquid broth, the treated cells are grown for 3 h at 28°C and plated on liquid broth/agar containing streptomycin (100 mg/L) and kanamycin (100 mg/L). The vector DNAs are then isolated from overnight cultures of individual LBA4404 colonies and examined by restriction analysis to confirm the presence of intact piasmid DNA.
Ten-fold dilutions of overnight-grown Agrobacterium cultures can be grown for 5-6 hours, precipitated for 15 minutes at 2,800 RPM, washed with MS liquid medium (Phytotechno!ogy) supplemented with sucrose (3%, pH 5.7), and resuspended in the same medium to 0.2 OD/600nm. The resuspended cells are mixed and used to infect 0.4-0.6 mm internodal segments of the potato varieties Ranger Russet, Russet Burbank, Atlantic, Phureja and Shepody.
Infected stems are incubated for two days on co-culture medium (1/10 MS salts.. 3% sucrose.. pH 5.7) containing 6 g/L agar at 22°C in a Percival growth chamber (16 hrs light) and subsequently transferred to callus induction medium (CIM, MS medium supplemented with 3% sucrose 3, 2.5 mg/L of zeatin riboside. 0.1 mg/L of naphthalene acetic acid, and 6g/L of agar) containing timentin (150 mg/L) and kanamycin (100 mg/L). After one month of culture on CIM, expiants are transferred to shoot induction medium (SIM, MS medium supplemented with 3% sucrose, 2.5 mg/L of zeatin riboside, 0.3 mg/L of giberellic acid GA3, and 6g/L of agar) containing timentin and kanamycin (150 and 100 mg/L respectively) until shoots arise. Shoots arising at the end of regeneration period are transferred to MS medium with 3% sucrose, 6 g/L of agar and timentin (150mg/L). Transgenic plants are transferred to soil and placed in a growth chamber.
The transformed plants are challenged by PVY as follows. First, an inoculum of PVY strain "NTN" or "0" is prepared fresh for each infection by grinding 5 g of systemicai!y infected tobacco tissue in 15 ml ice-cold phosphate buffer. The resulting suspension is filtered through miraclofh, and kept on ice. One drop of inoculum is gently rubbed on a single carborundum-dusted leaf from each plant transferred from tissue culture to soil six weeks earlier. Plants are grown for an additional 2-3 weeks to facilitate systemic viral spread and symptom development. All experiments are carried out in triplicate. Plants are assessed for the presence of PVY using the "ImmunoStrip" affinity assay that relies on previously characterized antibodies (Ellis et aL, 1996) and was developed by Agdia (Elkhart, IN).
In another embodiment, polynucleotide SEQ ID NO: 26, consisting of SEQ ID NO: 14-25, is operabiy linked to promoter Ubi7 SEQ ID NO: 58 and terminator Ubi3 SEQ ID MO: 59 to produce pSI 2202.
In another embodiment, polynucleotide SEQ ID MO: 39, consisting of SEQ ID NO: 27-38, is operabiy linked to promoter Ubi7 SEQ ID NO: 58 and terminator Ubi3 SEQ iD NO: 59 to produce pSI 2203.
In another embodiment, polynucleotide SEQ ID NO: 57, consisting of SEQ ID NO: 45, 48, 53, & 56 to produce pSI 2204, is operabiy linked to promoter Ubi7 SEQ ID NO: 58 and terminator Ubi3 SEQ ID NO: 59. Element 57 is not constructed the same way as 13, 26 and 39. In this case if is an miRNA approach and it contains much more potato sequences than PVY sequences.
Example 3 pSIM2201, pSI 2202, pSI 2203, and pS!M2204 were made according to the method described in Example 2, and transformed into Russet Burbank variety to produce transgenic potato plants RB-
2201, RB2202, RB 2203, and RB2204, respectively. RB-2201 plants contain a construct pSIM2201 with
SEQ ID 13 (combination of SEQ ID NOs: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 & 12). RB-2202 plants contain a construct pSIM2202 with SEQ ID 26 (combination of SEQ ID NOs: 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
& 25). RB-2203 plants contain a construct pSIM2203 with SEQ ID 39 (combination of SEQ ID NOs: 27, 28,
29.. 30, 31, 32, 33, 34, 35, 36, 37 & 38), and RB-2204 plants contain a construct pSI 2204 with SEQ ID
57 (combination of SEQ ID NOs: 45, 48, 53 & 56), PVY virus was rub-inoculated to the transgenic plants.
PVY immuno detection was performed by using lmmunoStrip®!SK 20001/0025 from Agdia.. 20 days post rub inoculation on Russet Burbank transgenic lines. The initial test result is shown in the table below'.
!br of plants PVY ImmunoStrip
Accession Observation
per Sine resu!ts
Russet Burbank 3 Positive Control plant is susceptible to PVYN i
RB-2201-1 3 Negative 1 accession susceptible to PVY' l !'out of 25 tested. Element 13 bring resistance against
RB-2201-2 3 Negative
RB-2201-3 3 egative
RB-2201-4 3 Negative
RB-2201-5 3 egative
RB-2201-6 3 Positive
RB-2201-7 3 Negative
RB-22Q1-8 3 Negative
RB-2201-9 3 Negative
RB-220 -10 3 Negative
RB-2201-11 3 Negative
RB-2201-12 3 Negative
RB-2201-13 3 Negative
RB-2201-14 3 Negative
RB-2201-15 3 egative
RB-2201-16 3 Negative
RB-22Q1-17 3 Negative
RB-2201-18 3 Negative
RB-2201-19 3 Negative
RB-220 -20 3 Negative
RB-2201-21 3 Negative
RB-2201-22 3 Negative
RB-2201-23 3 Negative
RB-2201-24 3 Negative
RB-22Q1-25 3 Negative
RB-2202-1 3 Positive 13 accessions susceptible to PVYN , out of 25 tested. Element 26 bring resistance against
RB-2202-2 3 Negative
RB-2202-3 3 Positive
RB-2202-4 3 Negative
RB-2202-5 3 Negative
RB-2202-6 3 Negative
RB-2202-7 3 Positive
RB-22Q2-8 3 Negative
RB-2202-9 3 Positive
RB-2202-10 3 Positive
RB-2202-11 3 Negative
RB-2202-12 3 Negative
RB-2202-13 3 Positive
RB-2202-14 3 Negative
RB-2202-15 3 Positive
RB-2202-16 3 Positive
RB-2202-17 3 Positive
RB-2202-18 3 Positive
RB-22Q2-19 3 Negative
RB-2202-20 3 Negative
RB-2202-21 3 Positive
RB-2202-22 3 Negative
RB-2202-23 3 Positive
RB-2202-24 3 egative
RB-2202-25 3 Positive
RB-2203-1 Positive 25 accessions susceptible to PVY1 ' 1 out of 25
RB-2203-4 3 Positive
RB-2203-5 3 Positive
RB-2203-6 3 Positive
RB-2203-7 3 Positive
RB-2203-8 3 Positive
RB-2203-9 3 Positive
RB-22Q3-10 3 Positive
RB-2203-11 3 Positive
RB-2203-12 3 Positive
RB-2203-13 3 Positive
RB-2203-14 3 1 plant Pos. 2 Neg.
RB-2203-15 3 2 plants Pos. 1 Neg.
RB-2203-16 3 Positive
RB-2203-17 3 Positive
RB-2203-18 3 Positive
RB-22Q3-19 3 Positive
RB-2203-20 3 Positive
RB-2203-21 3 Positive
RB-2203-22 3 Positive
RB-2203-23 3 Positive
RB-2203-24 3 Positive
RB-2203-25 2. Positive
3B-2204-1 3 Positive 5 accessions susceptible to PVY, lr|' out of 5
tested. Element 58 does not bring resistance
R 3-2204- 2 3 Positive
against PVYfJT ,
RB-2204-3 3 Positive
RB-2204-4 3 Positive
RB-2204-5 Positive
RB-2201 plants contain a construct with SEQ I D 13 (1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 & 12)
RB-2202 plants contain a construct with SEQ ID 26 (14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 & 25)
RB-2203 plants contain a construct with SEQ I D 39 (27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 & 38)
RB-2204 plants contain a construct with SEQ ID 57 (45, 48, 53 & 56)
Although transgenic plants RB-2203 and RB-2204 did not show obvious resistance to PVY in the initial trial, it does not mean that the silencing sequences targeting PYV in these vectors, i.e., SEQ ID NOs: 39 and 57, do not have the ability to induce PVY resistance in plants. It does not mean that every single sub-sequence within SEQ I D NQs: 39 or 57 could not be combined with other sequences to make additional vectors capable of inducing PVY resistance in plants. Many reasons may cause a false negative result. For example, there may be a particular mistake in pS!M2203 and pS! M2204 vetors; the vectors may have been suppressed in the plant genome; the vectors may not be particularly suitable for expressing SEQ ID NOs: 39 or 57 in plants since such sequences are much longer compared to other sequences; there may be a particular sub-sequence in the vectors that caused suppression of the expression of the whole vectors, etc. in addition, this is just one-time experiment so the negative data should not lead to a final conclusion that the vectors do not work.
Example 4
In one embodiment, a polynucleotide comprising at least two potato sequences selected from SEQ ID MO: 60-103, is operab!y linked to promoter Ubi7 SEQ ID NO: 58 and terminator Uhi3 SEQ ID NO: 59. The resulting expression cassette is positioned within a T-DNA region of a binary vector. This transformation vector will be introduced into an Agrobacterium strain such as LBA4404 or AGL-1 as described in Example 2 above.
In another embodiment, a polynucleotide comprising at least one viral sequence selected from SEQ ID MOs: 1-58, and at least one potato sequence selected from SEQ ID NOs: 60-103, is operabiy linked to promoter Ubi7 SEQ ID NO: 58 and terminator Ubi3 SEQ I D NO: 59. This transformation vector
will be introduced into an Agrobacterium strain such as LBA4404 or AGL-1 as described in Example 2 above.
The Agrobacterium strains are used to transform the polynucleotides info a plant, such as a potato plant to confer resistance to PVY.
Unless defined otherwise, ail technical and scientific terms herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods and materials, similar or equivalent to those described herein, can be used in the practice or testing of the present invention, the preferred methods and materials are described herein. All publications, patents, and patent publications cited are incorporated by reference herein in their entirety for ail purposes.
The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Mothing herein is to be construed as an admission that the present invention is not entitled to antedate such publication by virtue of prior invention.
While the invention has been described in connection with specific embodiments thereof, it will be understood that it is capable of further modifications and this application is intended to cover any variations, uses, or adaptations of the invention following, in general, the principles of the invention and including such departures from the present disclosure as come within known or customary practice within the art to which the invention pertains and as may be applied to the essential features hereinbefore set forth and as follows in the scope of the appended claims.
Claims
1. An isolated po!ynuc!eotide comprising one or more plant DNA sequences, wherein each plant DMA sequence shares sequence homology to a corresponding DMA sequence from the genome(s) of at least one strain of Potato Virus Y.
2. The isolated polynucleotide of claim 1, comprising 2, 3, 4, 5, 6, 1, 8, 9, 10, or more than 1.0 plant DNA sequences.
3. The isolated polynucleotide of claim 1, wherein each plant DNA sequence shares at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or at least 100%, sequence homology with a PVY DNA sequence.
4. The isolated polynucleotide of claim 1, wherein the plant DMA sequences are potato plant DMA sequences.
5. An expression vector comprising a promoter operably linked to a polynucleotide comprising multiple plant DMA sequences, wherein each plant DMA sequence shares sequence homology to a corresponding DNA sequence from the genome(s) of at least one strain of Potato Virus Y.
6. A method for conferring full or partial resistance in a plant to at least one strain of Potato Virus Y infection, comprising expressing in a plant a polynucleotide that comprises multiple plant DMA sequences, wherein each plant DNA sequence shares sequence homology, in the sense or antisense orientation, to a corresponding DMA sequence from the genome(s) of at least one strain of Potato Virus Y, wherein the plant is fully or partially resistant to PVY infection compared to a plant of the same species that does not express the polynucleotide.
7. The method of claim 6, wherein the plant is a potato plant.
8. The method of claim 6., wherein the plant DMA sequences are potato plant DMA sequences.
9. The method of claim 6, wherein the plant is a potato plant and the plant DMA sequences are potato plant DMA sequences.
34
10. The isolated polynucleotide of claim 1, wherein the polynucleotide comprises at least two sequences selected from the SEQ ID NOs,: 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, and 71.
11. The isolated polynucleotide of claim 10, wherein the polynucleotide comprises at least two sequences having at least 90% identity to SEQ ID NO: 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, or 71.
12. The isolated polynucleotide of claim 1, wherein the polynucleotide comprises at least two sequences selected from the SEQ ID NOs,: 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, and 83, or at least two sequences selected from the SEQ ID NOs,: 84, 85,86,87, 88, 89, 90, 91, 92, 93, 94, and 95, or at least two sequences selected from the SEQ ID NOs.: 96, 97, 98, 99, 100, 101, 102, and 103, or at least two sequences selected from the SEQ ID NO.s 72-103,
13. The isolated polynucleotide of claim 12, wherein the polynucleotide comprises at least two sequences having at least 90% identity to SEQ I NO: 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, or 83, or at least two sequences having at least 90% identity to SEQ ID NOs.: 84, 85,86,87, 88, 89, 90, 91, 92, 93, 94, or 95, or at least two sequences having at least 90% identity to SEQ ID NOs.: 96, 97, 98, 99, 100, 101, 102, or 103, or at least two sequences having at least 90% identity to any one of SEQ ID NO.s 72- 103.
14. An isolated polynucleotide comprising one or more viral DNA sequences, wherein each viral DNA sequence shares sequence homology to a corresponding DNA sequence from the genome(s) of at least one plant.
15. The isolated polynucleotide of claim 14, comprising 2, 3, 4, 5, 6, 7, 8, 9, 10, or more than 10 plant DNA sequences.
16. The isolated polynucleotide of claim 14, wherein each viral DNA sequence shares at least 8096, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or at least 100%, sequence homology with a potato plant DNA sequence.
17. The isolated polynucleotide of claim 14, wherein the viral DNA sequences are Potato Virus Y DNA sequences.
35
18. An expression vector comprising a promoter operab!y linked to a polynucleotide comprising multiple viral DNA sequences, wherein each viral DNA sequence shares sequence homology to a corresponding DNA sequence from the genome(s) of at least one potato plant,
19. A method for conferring full or partial resistance in a piant to at least one strain of Potato Virus Y infection, comprising expressing in a plant a polynucleotide that comprises multiple viral DNA sequences, wherein each viral DNA sequence shares sequence homology, in the sense or antisense orientation, to a corresponding DNA sequence from the genome(s) of at least one potato plant., wherein the plant is fully or partially resistant to PVY infection compared to a plant of the same species that does not express the polynucleotide.
20. The method of claim 19, wherein the plant is a potato plant.
21. The method of claim 19, wherein the viral DMA sequences are Potato Virus Y DNA sequences.
22. The method of claim 19, wherein the plant is a potato plant and the viral DNA sequences are Potato Virus Y DNA sequences.
23. The isolated polynucleotide of claim 14, wherein the polynucleotide comprises at least two sequences selected from the SEQ ID NOs,: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12.
24. The isolated polynucleotide of claim 23, wherein the polynucleotide comprises the sequence of SEQ ID NO: 13.
25. The isolated polynucleotide of claim 14, wherein the polynucleotide comprises at least two sequences selected from the SEQ ID NOs,: 14, 15, 16, 17, 18, 19.. 20, 21, 22, 23, 24, and 25.
26. The isolated polynucleotide of claim 25, wherein the polynucleotide comprises the sequence of SEQ ID NO: 26.
27. The isolated polynucleotide of claim 14, wherein the polynucleotide comprises at least two sequences selected from the SEQ ID NOs,: 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, and 38.
28. The isolated polynucleotide of claim 27, wherein the polynucleotide comprises the sequence of SEQ ID NO: 39.
36
29, The isolated polynucleotide of claim 14. wherein the polynucleotide comprises at least two sequences selected from the SEQ ID NOs,: 45, 48, 53, and 57.
30. The isolated polynucleotide of claim 29, wherein the polynucleotide comprises the sequence of SEQ ID NO: 58.
31. The expression vector of claim 5, comprising a polynucleotide that comprises one or more sequences selected from the group consisting of SEQ ID NOs: 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85,86,87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, and 103.
32. The expression vector of claim 18, comprising a polynucleotide that comprises one or more sequences selected from the group consisting of SEQ ID NOs: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 45, 48, 53, and 57.
33. The method of claim 6, wherein the polynucleotide comprises one or more sequences selected from the group consisting of SEQ ID NOs: 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85,86,87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, and 103.
34. The method of claim 19, wherein the polynucleotide comprises one or more sequences selected from the group consisting of SEQ ID NOs: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 45, 48, 53, and 57.
35. The isolated polynucleotide of claim 1, wherein the isolated polynucleotide comprising comprises one or more sequences selected from the group consisting of:
{1} complements of a sequence o 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85,86,87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, and 103 ;
(2) reverse complements of a sequence of 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85,86,87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, and 103;
37
(3) reverse sequences a sequence of 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85,86,87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, and 103;
(4) a portion of a nucleotide sequence comprising at least 15 contiguous nucleotides of a nucleotide sequence selected from the group consisting of a nucleotide sequence recited in (1) -(3);
(5) a nucleotide sequence having at least 95% identity to a nucleotide sequence recited in (1) -
(3);
(6) a nucleotide sequence having an E value of 0.01 when aligned with a sequence recited in (1) -(3); and
(7) a nucleotide sequences that hybridize to a sequence recited in (1} -(3) under stringent conditions, wherein said stringent conditions are hybridization in 0.25 M Na2HP04 buffer (pH 7.2) containing 1 mM Na2EDTA, 20% sodium dodecyi sulfate at 45°C, followed by a wash in 5xSSC, containing 0.1% (w/v) sodium dodecyi sulfate, at 55°C to 65"C.
36. The isolated polynucleotide of claim 14, wherein the isolated polynucleotide comprising comprises one or more sequences selected from the group consisting of:
(1) complements of a sequence of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 45, 48, 53, and 57;
(2) reverse complements of a sequence of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 45, 48, 53, and 57;
(3) reverse sequences a sequence of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 45, 48, 53, and 57;
(4) a portion of a nucleotide sequence comprising at least 15 contiguous nucleotides of a nucleotide sequence selected from the group consisting of a nucleotide sequence recited in (1) -(3);
(5) a nucleotide sequence having at least 95% identity to a nucleotide sequence recited in (1) -
(3);
38
(6) a nucleotide sequence having an E value of 0,01 when aligned with a sequence recited in (1) -(3); and
(7) a nucleotide sequences that hybridize to a sequence recited in (1) -(3) under stringent conditions, wherein said stringent conditions are hybridization in 0.25 M Na2HP04 buffer (pH 7,2) containing 1 rn Na2EDTA, 20% sodium dodecyl sulfate at 45°C, followed by a wash in 5xSSC, containing 0.1% (w/v) sodium dodecyl sulfate, at 55°C to 65°C.
37. The expression vector of claim 5, comprising a polynucleotide that comprises one or more sequences selected from the isolated polynucleotide of claim 35.
38. The expression vector of claim 18, comprising a polynucleotide that comprises one or more sequences selected from the isolated polynucleotide of claim 36.
39. The method of claim 6, wherein the polynucleotide comprises one or more sequences selected from the isolated polynucleotide of claim 35.
40. The method of claim 19, wherein the polynucleotide comprises one or more sequences selected from the isolated polynucleotide of claim 36.
41. A transgenic cell comprising the isolated polynucleotide of claim 1, 14, 35, or 36.
42. An organism comprising the transgenic cell of claim 41.
43. A transformed plant, plant part or plant ceil comprising the isolated polynucleotide of claim 1, 14, 35, or 36.
44. A seed of the transformed plant of claim 43, wherein said seed comprises said isolated polynucleotide.
45. Progeny plants of the plant of claim 43, wherein the progeny plants have an altered pathogen tolerance and/or resistance as a result of inheriting the polynucleotide.
46. A method of producing hybrid seed comprising crossing the plant of claim 43 or a progeny plant of claim 45 with a different plant of the same species, and harvesting the resultant seed.
39
47. A method for producing a plant having altered pathogen tolerance and/or resistance comprising: (a) transforming a plant ceil with an expression vector to provide a transgenic cell., wherein the expression vector comprises: (i) a promoter sequence; (ii) an isolated polynucleotide sequence of claim 1, 14, 35, or 36; and (iii) a gene termination sequence; and (b) cultivating the transgenic cell under conditions conducive to regeneration and mature plant growth of a plant having altered pathogen tolerance and/or resistance.
48. A method for modifying a phenotype of a target organism, comprising stably incorporating into the genome of the target organism a genetic construct comprising: {a} a promoter sequence; (b) an isolated polynucleotide sequence of claim 1, 1.4, 35, or 36; and (c) a gene termination sequence.
49. The method of claim 48, wherein the target organism is a plant.
50. A process of determining the presence or absence of an isolated polynucleotide sequence of claim 1, 1.4, 35, or 36 and fragments and variations thereof in a plant, wherein the process comprises at least one of:
(a) isolating nucleic acid molecules from said plant and amplifying sequences homologous to the polynucleotide; and/or
(b) isolating nucleic acid molecules from said plant and performing a hybridization to detect the polynucleotide; and/or
(c) demonstrating the presence of nnRNA sequences derived from a polynucleotide mRNA transcript and unique to the polynucleotide.
51. A method of breeding plants to produce altered pathogen tolerance and/or resistance comprising:
1} making a cross between a plant with an isolated polynucleotide sequence of claim 1, 14, 35, or 36 with a second plant to produce a Fl plant; ii) backcrossing the Fl plant to the second plant; and
40
iii) repeating the backcrossing step to generate a near isogenic or isogenic line, wherein the isolated polynucleotide sequence of claim 1, 14, 35, or 36 is integrated into the genome of the second plant and the near isogenic or isogenic line derived from the second plant with the isolated polynucleotide sequence has conferred or enhanced pathogen tolerance and/or resistance compared to that of the second plant without the isolated polynucleotide sequence.
52. An isolated polynucleotide comprising one or more plant DNA sequences, wherein each plant DMA sequence shares sequence homology to a corresponding DMA sequence from the genome(s) of at least one strain of Potato Virus Y, and one or more viral DNA sequences, wherein each viral DMA sequence shares sequence homology to a corresponding DMA sequence from the genome(s) of at least one potato plant.
53. The isolated polynucleotide of claim 52, wherein the plant DMA sequences are selected from the sequences of claims 1-4, 10-13, and 35, and wherein the viral DNA sequences are selected from the sequences of claims 14-17, 23-30, and 36.
54. An expression vector comprising a promoter operably linked to a polynucleotide comprising the isolated polynucleotide of claim 52 or 53.
55. A method for conferring full or partial resistance in a plant to at least one strain of Potato Virus Y infection, comprising expressing in a plant a polynucleotide of claim 52 or 53.
56. A transgenic cell comprising the isolated polynucleotide of claim 52 or 53.
57. An organism comprising the transgenic cell of claim 56.
58. A transformed plant, plant part or plant cell comprising the isolated polynucleotide of claim 52 or 53.
59. A seed of the transformed plant of claim 58, wherein said seed comprises said isolated polynucleotide.
60. Progeny plants of the plant of claim 58, wherein the progeny plants have an altered pathogen tolerance and/or resistance as a result of inheriting the polynucleotide.
41
61. A method of producing hybrid seed comprising crossing the plant of claim 58 or a progeny plant of claim 59 with a different plant of the same species, and harvesting the resultant seed,
62. A method for producing a plant having altered pathogen tolerance and/or resistance comprising: (a) transforming a plant ceil with an expression vector to provide a transgenic cell, wherein the expression vector comprises: (i) a promoter sequence; (ii) an isolated polynucleotide sequence of claim 52 or 53; and (iii) a gene termination sequence; and (b) cultivating the transgenic cell under conditions conducive to regeneration and mature plant growth of a plant having altered pathogen tolerance and/or resistance.
63. A method for modifying a phenotype of a target organism, comprising stably incorporating into the genome of the target organism a genetic construct comprising: (a) a promoter sequence; (b) an isolated poiynucieotide sequence of claim 52 or 53; and (c) a gene termination sequence.
64. A process of determining the presence or absence of an isolated poiynucieotide sequence of claim 52 or 53 and fragments and variations thereof in a plant, wherein the process comprises at least one of:
(a) isolating nucleic acid molecules from said plant and amplifying sequences homologous to the polynucleotide; and/or
(b) isolating nucleic acid molecules from said plant and performing a hybridization to detect the polynucleotide; and/or
(c) demonstrating the presence of mRNA sequences derived from a polynucleotide mRNA transcript and unique to the polynucleotide.
65. A method of breeding plants to produce altered pathogen tolerance and/or resistance comprising: i) making a cross between a plant with an isolated polynucleotide sequence of claim 52 or 53 with a second plant to produce a Fl plant; ii) backcrossing the Fl plant to the second plant; and
42
iii) repeating the backcrossing step to generate a near isogenic or isogenic line, wherein the isolated polynucleotide sequence of claim 52 or 53 is integrated into the genome of the second plant and the near isogenic or isogenic line derived from the second plant with the isolated polynucleotide sequence has conferred or enhanced pathogen tolerance and/or resistance compared to that of the second plant without the isolated polynucleotide sequence.
43
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261663467P | 2012-06-22 | 2012-06-22 | |
US61/663,467 | 2012-06-22 | ||
US201361783342P | 2013-03-14 | 2013-03-14 | |
US61/783,342 | 2013-03-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2013192613A2 true WO2013192613A2 (en) | 2013-12-27 |
WO2013192613A3 WO2013192613A3 (en) | 2014-04-03 |
Family
ID=49769740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2013/047329 WO2013192613A2 (en) | 2012-06-22 | 2013-06-24 | Pvy resistance |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2013192613A2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6228637B1 (en) * | 1992-10-21 | 2001-05-08 | Japan Tobacco, Inc. | Recombinant vector, method for giving immunity against PVY-T to potato plant, and potato plant having immunity against PVY-T |
US20110271409A1 (en) * | 2006-05-25 | 2011-11-03 | George James Baley | Method to identify disease resistant quantitative trait loci in soybean and compositions thereof |
US20120102589A1 (en) * | 2010-10-18 | 2012-04-26 | J.R. Simplot Company | Potyvirus resistance in potato |
-
2013
- 2013-06-24 WO PCT/US2013/047329 patent/WO2013192613A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6228637B1 (en) * | 1992-10-21 | 2001-05-08 | Japan Tobacco, Inc. | Recombinant vector, method for giving immunity against PVY-T to potato plant, and potato plant having immunity against PVY-T |
US20110271409A1 (en) * | 2006-05-25 | 2011-11-03 | George James Baley | Method to identify disease resistant quantitative trait loci in soybean and compositions thereof |
US20120102589A1 (en) * | 2010-10-18 | 2012-04-26 | J.R. Simplot Company | Potyvirus resistance in potato |
Non-Patent Citations (6)
Also Published As
Publication number | Publication date |
---|---|
WO2013192613A3 (en) | 2014-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9688984B2 (en) | SPL16 compositions and methods to increase agronomic performance of plants | |
CN111511920A (en) | Novel resistance genes associated with disease resistance in soybean | |
JP6871252B2 (en) | Tissue-preferred promoters and how to use them | |
US20160138041A1 (en) | Identification of a xanthomonas euvesicatoria resistance gene from pepper (capsicum annuum) and method for generating plants with resistance | |
US10221425B2 (en) | BG1 compositions and methods to increase agronomic performance of plants | |
WO2012149316A2 (en) | miRNA396 AND GROWTH REGULATING FACTORS FOR CYST NEMATODE TOLERANCE IN PLANTS | |
AU2018206894A1 (en) | Isolated polynucleotides and polypeptides associated with plants resistance to pathogenic fungi | |
UA127447C2 (en) | Methods for transfecting plants and for reducing random integration events | |
WO2017000089A1 (en) | Biotechnological breeding method for obtaining antiviral seedless grapes | |
RU2714724C2 (en) | Constitutive soya promoters | |
Meiyalaghan et al. | Structure and expression of GSL1 and GSL2 genes encoding gibberellin stimulated-like proteins in diploid and highly heterozygous tetraploid potato reveals their highly conserved and essential status | |
WO2013177376A2 (en) | Dirigent gene eg261 and its orthologs and paralogs and their uses for pathogen resistance in plants | |
US20150024388A1 (en) | Expression of SEP-like Genes for Identifying and Controlling Palm Plant Shell Phenotypes | |
CN109134633A (en) | Blast resisting albumen and gene, the nucleic acid of separation and its application | |
US20210010014A1 (en) | Peanut with reduced allergen levels | |
WO2012006866A1 (en) | BOTANICAL YELLOW DWARF DISEASE RESISTANT PROTEIN TiSTKI, CODING GENE AND APPLICATION THEREOF | |
CN106987591B (en) | Photoinduction type promoter gene and application thereof | |
US9587248B2 (en) | Mayetiola destructor susceptibility gene one (Mds-1) and its application in pest management | |
US20070074313A1 (en) | Native antibiotic resistance genes | |
WO2013192613A2 (en) | Pvy resistance | |
AU2015313886A1 (en) | Methods and materials for producing fruit of altered size | |
US9051580B2 (en) | Genes and methods for increasing disease resistance in plants | |
Deák et al. | Candidate plant gene homologues in grapevine involved in Agrobacterium transformation | |
US20180355370A1 (en) | Dreb repressor modifications and methods to increase agronomic performance of plants | |
WO2013158966A1 (en) | Bronze bug control agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13807711 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13807711 Country of ref document: EP Kind code of ref document: A2 |